<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2025//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_250101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">39932201</PMID><DateCompleted><Year>2025</Year><Month>04</Month><Day>15</Day></DateCompleted><DateRevised><Year>2025</Year><Month>04</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>68</Volume><Issue>5</Issue><PubDate><Year>2025</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Enhanced Recovery Independently Lowers Failure to Rescue After Colorectal Surgery.</ArticleTitle><Pagination><StartPage>616</StartPage><EndPage>626</EndPage><MedlinePgn>616-626</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003655</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High adherence to the enhanced recovery after surgery pathway reduces morbidity and mortality rates after elective colorectal surgery.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To evaluate the effect of adherence to the enhanced recovery after surgery pathway on the failure to rescue rates after elective colorectal surgery.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective analysis of a prospective database.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Adults (18 years or older) who underwent elective colorectal resection with anastomosis for benign and malignant disease.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Prospective enrollment in 78 centers in Italy from 2019 to 2021.</AbstractText><AbstractText Label="INTERVENTIONS" NlmCategory="METHODS">All outcomes were measured 60 days after surgery. Several patient-, disease-, treatment-, hospital-, and complication-related variables were analyzed. After univariate analyses, independent predictors of the end points were identified through logistic regression analyses, presenting ORs and 95% CIs.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Failure to rescue after any adverse event, defined as the ratio between the number of deaths and the number of patients showing any adverse event; failure to rescue after any major adverse event, with the denominator represented by the number of patients showing any major adverse event.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">An adverse event was recorded in 2321 of 8359 patients (27.8%), a major adverse event in 523 patients (6.3%), and death in 88 patients (1.0%). The failure to rescue rates were 3.8% after any adverse event and 16.8% after any major adverse event. Independent predictors of primary end points were identified among patient- (age, ASA class, and nutritional status), treatment- (type of resection), and complication-related (anastomotic leakage and reoperation) variables. Enhanced recovery pathway adherence of more than 70% independently reduced failure to rescue rates.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Clustering from multicenter data and unmeasured confounding from observational data.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">After elective colorectal resection, adherence of more than 70% to the enhanced recovery pathway independently decreased failure to rescue rates, along with other patient- or treatment-related factors. See Video Abstract .</AbstractText><AbstractText Label="LA RECUPERACIN MEJORADA REDUCE DE FORMA INDEPENDIENTE LA POSIBILIDAD DE FRACASO EN EL RESCATE DESPUS DE UNA CIRUGA COLORRECTAL" NlmCategory="UNASSIGNED">ANTECEDENTES:La alta adherencia a la v&#xed;a de recuperaci&#xf3;n mejorada despu&#xe9;s de la cirug&#xed;a reduce las tasas de morbilidad y mortalidad despu&#xe9;s de la cirug&#xed;a colorrectal electiva.OBJETIVO:Evaluar el efecto de la adherencia a la v&#xed;a ERAS en las tasas de fracaso en el rescate despu&#xe9;s de la cirug&#xed;a colorrectal electiva.DISE&#xd1;O:An&#xe1;lisis retrospectivo de una base de datos prospectiva.PACIENTES:Adultos (&#x2265; 18 a&#xf1;os) que se sometieron a una resecci&#xf3;n colorrectal electiva con anastomosis por enfermedad benigna y maligna.ESCENARIO:Inscripci&#xf3;n prospectiva en 78 centros en Italia de 2019 a 2021.INTERVENCIONES:Todos los resultados se midieron a los 60 d&#xed;as despu&#xe9;s de la cirug&#xed;a. Se analizaron varias variables relacionadas con el paciente, la enfermedad, el tratamiento, el hospital y las complicaciones para los resultados. Despu&#xe9;s de los an&#xe1;lisis univariados, se identificaron los predictores independientes de los puntos finales a trav&#xe9;s de an&#xe1;lisis de regresi&#xf3;n log&#xed;stica, presentando razones de probabilidades e intervalos de confianza del 95%.PRINCIPALES MEDIDAS DE RESULTADOS:Fallo en el rescate despu&#xe9;s de cualquier evento adverso, definido como la relaci&#xf3;n entre el n&#xfa;mero de muertes y el n&#xfa;mero de pacientes que presentaron cualquier evento adverso; fallo en el rescate despu&#xe9;s de cualquier evento adverso mayor, con el denominador representado por el n&#xfa;mero de pacientes que presentaron cualquier evento adverso mayor.RESULTADOS:Se registr&#xf3; un evento adverso en 2321 de 8359 pacientes (27,8%), un evento adverso mayor en 523 pacientes (6,3%) y muerte en 88 pacientes (1,0%). Las tasas de fallo en el rescate fueron del 3,8% despu&#xe9;s de cualquier evento adverso y del 16,8% despu&#xe9;s de cualquier evento adverso mayor. Se identificaron predictores independientes de los criterios de valoraci&#xf3;n primarios entre las variables relacionadas con el paciente (edad, clase de la Sociedad Americana de Anestesi&#xf3;logos, estado nutricional), el tratamiento (tipo de resecci&#xf3;n) y las complicaciones (fuga anastom&#xf3;tica, reoperaci&#xf3;n). La adherencia a la v&#xed;a de recuperaci&#xf3;n mejorada &gt; 70% redujo de forma independiente las tasas de fallo en el rescate.LIMITACIONES:Agrupamiento de datos multic&#xe9;ntricos y factores de confusi&#xf3;n no medidos a partir de datos observacionales.CONCLUSIONES:Despu&#xe9;s de una resecci&#xf3;n colorrectal electiva, la adherencia &gt; 70 % a la v&#xed;a de recuperaci&#xf3;n mejorada disminuy&#xf3; de manera independiente las tasas de fracaso en el rescate, junto con otros factores relacionados con el paciente o el tratamiento. (Traducci&#xf3;n-Dr Osvaldo Gauto).</AbstractText><CopyrightInformation>Copyright &#xa9; 2025 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Colon and Rectal Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Catarci</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-6338-0114</Identifier><AffiliationInfo><Affiliation>General Surgery Unit, Sandro Pertini Hospital, ASL Roma 2, Roma, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruffo</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-5259-7652</Identifier><AffiliationInfo><Affiliation>General Surgery Unit, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella (VR), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Viola</LastName><ForeName>Massimo Giuseppe</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>General Surgery Unit, Cardinale G. Panico Hospital, Tricase (LE), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garulli</LastName><ForeName>Gianluca</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-6023-6117</Identifier><AffiliationInfo><Affiliation>General Surgery Unit, Infermi Hospital, Rimini, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pavanello</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-8915-8175</Identifier><AffiliationInfo><Affiliation>General Surgery Unit, AULSS2 Marca Trevigiana, Conegliano Veneto (TV), Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scatizzi</LastName><ForeName>Marco</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0753-9450</Identifier><AffiliationInfo><Affiliation>General Surgery Unit, Santa Maria Annunziata and Serristori Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bottino</LastName><ForeName>Vincenzo</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5846-9990</Identifier><AffiliationInfo><Affiliation>General and Oncologic Surgery Unit, Evangelico Betania Hospital, Napoli, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guadagni</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-8525-084</Identifier><AffiliationInfo><Affiliation>General Surgery Unit, Universit&#xe0; degli Studi dell'Aquila, L'Aquila, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Italian ColoRectal Anastomotic Leakage (iCral) study group</CollectiveName></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName><AccessionNumberList><AccessionNumber>NCT03771456</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2025</Year><Month>02</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080482" MajorTopicYN="Y">Enhanced Recovery After Surgery</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011183" MajorTopicYN="Y">Postoperative Complications</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017558" MajorTopicYN="Y">Elective Surgical Procedures</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007558" MajorTopicYN="N" Type="Geographic">Italy</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000067248" MajorTopicYN="Y">Failure to Rescue, Health Care</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003082" MajorTopicYN="Y">Colectomy</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003107" MajorTopicYN="Y">Colorectal Surgery</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Colorectal surgery</Keyword><Keyword MajorTopicYN="N">Enhanced recovery after surgery</Keyword><Keyword MajorTopicYN="N">Failure to rescue</Keyword></KeywordList><CoiStatement><b>Financial Disclosure:</b> Dr. Catarci reports personal fees from Baxter Spa outside the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2025</Year><Month>4</Month><Day>15</Day><Hour>18</Hour><Minute>24</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2025</Year><Month>2</Month><Day>11</Day><Hour>12</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2025</Year><Month>2</Month><Day>11</Day><Hour>8</Hour><Minute>3</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>4</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39932201</ArticleId><ArticleId IdType="pmc">PMC11999097</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003655</ArticleId><ArticleId IdType="pii">00003453-990000000-00869</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Silber JH, Williams SV, Krakauer H, Schwartz JS. Hospital and patient characteristics associated with death after surgery. A study of adverse occurrence and failure to rescue. Med Care. 1992;30:615&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">1614231</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosero EB, Modrall JG, Joshi GP. Failure to rescue after major abdominal surgery: the role of hospital safety net burden. Am J Surg. 2020;220:1023&#x2013;1030.</Citation><ArticleIdList><ArticleId IdType="pubmed">32199603</ArticleId></ArticleIdList></Reference><Reference><Citation>Portuondo JI, Shah SR, Singh H, Massarweh NN. Failure to rescue as a surgical quality indicator: current concepts and future directions for improving surgical outcomes. Anesthesiology. 2019;131:426&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pubmed">30860985</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells CI, Bhat S, Xu W, et al. . Variation in the definition of &#x2018;failure to rescue&#x2019; from postoperative complications: a systematic review and recommendations for outcome reporting. Surgery. 2024;175:1103&#x2013;1110.</Citation><ArticleIdList><ArticleId IdType="pubmed">38245447</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo-Felipe M, Ahl Hulme R, Sjolin G, et al. . Hospital academic status is associated with failure-to-rescue after colorectal cancer surgery. Surgery. 2021;170:863&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pubmed">33707039</ArticleId></ArticleIdList></Reference><Reference><Citation>Henneman D, van Leersum NJ, Ten Berge M, et al. . Failure-to-rescue after colorectal cancer surgery and the association with three structural hospital factors. Ann Surg Oncol. 2013;20:3370&#x2013;3376.</Citation><ArticleIdList><ArticleId IdType="pubmed">23732859</ArticleId></ArticleIdList></Reference><Reference><Citation>Pandit V, Jehan F, Zeeshan M, et al. . Failure to rescue in postoperative patients with colon cancer: time to rethink where you get surgery. J Surg Res. 2019;234:1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30527459</ArticleId></ArticleIdList></Reference><Reference><Citation>Lillo-Felipe M, Ahl Hulme R, Forssten MP, et al. . Center-level procedure volume does not predict failure-to-rescue after severe complications of oncologic colon and rectal surgery. World J Surg. 2021;45:3695&#x2013;3706.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8572842</ArticleId><ArticleId IdType="pubmed">34448919</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko A, Aquino L, Melo N, Alban RF. Surgical outcomes and failure-to-rescue events after colectomy in teaching hospitals: a nationwide analysis. Am J Surg. 2016;212:1133&#x2013;1139.</Citation><ArticleIdList><ArticleId IdType="pubmed">27765178</ArticleId></ArticleIdList></Reference><Reference><Citation>Spolverato G, Gennaro N, Zorzi M, et al. . Failure to rescue as a source of variation in hospital mortality after rectal surgery: the Italian experience. Eur J Surg Oncol. 2019;45:1219&#x2013;1224.</Citation><ArticleIdList><ArticleId IdType="pubmed">30904244</ArticleId></ArticleIdList></Reference><Reference><Citation>Almoudaris AM, Burns EM, Mamidanna R, et al. . Value of failure to rescue as a marker of the standard of care following reoperation for complications after colorectal resection. Br J Surg. 2011;98:1775&#x2013;1783.</Citation><ArticleIdList><ArticleId IdType="pubmed">22034183</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells CI, Varghese C, Boyle LJ, et al. . &#x201c;Failure to rescue&#x201d; following colorectal cancer resection: variation and improvements in a national study of postoperative mortality. Ann Surg. 2023;278:87&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pubmed">35920564</ArticleId></ArticleIdList></Reference><Reference><Citation>Greco M, Capretti G, Beretta L, Gemma M, Pecorelli N, Braga M. Enhanced recovery program in colorectal surgery: a meta-analysis of randomized controlled trials. World J Surg. 2014;38:1531&#x2013;1541.</Citation><ArticleIdList><ArticleId IdType="pubmed">24368573</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll&#xe9;s-Melchor J, Ram&#xed;rez-Rodr&#xed;guez JM, Casans-Franc&#xe9;s R, et al. ; POWER Study Investigators Group for the Spanish Perioperative Audit and Research Network (REDGERM). Association between use of enhanced recovery after surgery protocol and postoperative complications in colorectal surgery: the postoperative outcomes within enhanced recovery after surgery protocol (POWER) study. JAMA Surg. 2019;154:725&#x2013;736.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6506896</ArticleId><ArticleId IdType="pubmed">31066889</ArticleId></ArticleIdList></Reference><Reference><Citation>Berian JR, Ban KA, Liu JB, Ko CY, Feldman LS, Thacker JK. Adherence to enhanced recovery protocols in NSQIP and association with colectomy outcomes. Ann Surg. 2019;269:486&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">29064887</ArticleId></ArticleIdList></Reference><Reference><Citation>Ripoll&#xe9;s-Melchor J, Abad-Motos A, Cecconi M, et al. ; EuroPOWER Study Investigators Group. Association between use of enhanced recovery after surgery protocols and postoperative complications in colorectal surgery in Europe: the EuroPOWER international observational study. J Clin Anesth. 2022;80:110752.</Citation><ArticleIdList><ArticleId IdType="pubmed">35405517</ArticleId></ArticleIdList></Reference><Reference><Citation>Catarci M, Ruffo G, Viola MG, et al. ; on behalf of the Italian ColoRectal Anastomotic Leakage (iCral) study group. High adherence to enhanced recovery pathway independently reduces major morbidity and mortality rates after colorectal surgery: a reappraisal of the iCral2 and iCral3 multicenter prospective studies. Il Giornale di Chirurgia - J Italian Assoc Hospital Surg. 2023;43:e24.</Citation></Reference><Reference><Citation>Catarci M, Ruffo G, Viola MG, et al. ; Italian ColoRectal Anastomotic Leakage (iCral) study group. ERAS program adherence-institutionalization, major morbidity and anastomotic leakage after elective colorectal surgery: the iCral2 multicenter prospective study. Surg Endosc. 2022;36:3965&#x2013;3984.</Citation><ArticleIdList><ArticleId IdType="pubmed">34519893</ArticleId></ArticleIdList></Reference><Reference><Citation>Italian ColoRectal Anastomotic Leakage (iCral) study group. Patient-reported outcomes, return to intended oncological therapy and enhanced recovery pathways after colorectal surgery: a prospective multicenter observational investigation by the Italian ColoRectal Anastomotic Leakage (iCral 3) study group. Ann Surg Open. 2023;4:e267.</Citation></Reference><Reference><Citation>von EE, Altman DG, Egger M, et al. . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344&#x2013;349.</Citation><ArticleIdList><ArticleId IdType="pubmed">18313558</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Scott MJ, Hubner M, et al. . Guidelines for perioperative care in elective colorectal surgery: Enhanced Recovery After Surgery (ERAS&#xae;) Society recommendations: 2018. World J Surg. 2019;43:659&#x2013;695.</Citation><ArticleIdList><ArticleId IdType="pubmed">30426190</ArticleId></ArticleIdList></Reference><Reference><Citation>Ficari F, Borghi F, Catarci M, et al. . Enhanced recovery pathways in colorectal surgery: a consensus paper by the Associazione Chirurghi Ospedalieri Italiani (ACOI) and the PeriOperative Italian Society (POIS). G Chir. 2019;40(suppl):1&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">32003714</ArticleId></ArticleIdList></Reference><Reference><Citation>Clavien PA, Barkun J, de Oliveira ML, et al. . The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pubmed">19638912</ArticleId></ArticleIdList></Reference><Reference><Citation>Katayama H, Kurokawa Y, Nakamura K, et al. . Extended Clavien-Dindo classification of surgical complications: Japan Clinical Oncology Group postoperative complications criteria. Surg Today. 2016;46:668&#x2013;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4848327</ArticleId><ArticleId IdType="pubmed">26289837</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahbari NN, Weitz J, Hohenberger W, et al. . Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the International Study Group of Rectal Cancer. Surgery. 2010;147:339&#x2013;351.</Citation><ArticleIdList><ArticleId IdType="pubmed">20004450</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser MJ, Bauer JM, Ramsch C, et al. ; MNA-International Group. Validation of the Mini Nutritional Assessment short-form (MNA-SF): a practical tool for identification of nutritional status. J Nutr Health Aging. 2009;13:782&#x2013;788.</Citation><ArticleIdList><ArticleId IdType="pubmed">19812868</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim JH. Multicollinearity and misleading statistical results. Korean J Anesthesiol. 2019;72:558&#x2013;569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6900425</ArticleId><ArticleId IdType="pubmed">31304696</ArticleId></ArticleIdList></Reference><Reference><Citation>ESCP Enhanced Recovery Collaborating Group. An international assessment of the adoption of enhanced recovery after surgery (ERAS&#xae;) principles across colorectal units in 2019-2020. Colorectal Dis. 2021;23:2980&#x2013;2987.</Citation><ArticleIdList><ArticleId IdType="pubmed">34365718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lafonte M, Cai J, Lissauer ME. Failure to rescue in the surgical patient: a review. Curr Opin Crit Care. 2019;25:706&#x2013;711.</Citation><ArticleIdList><ArticleId IdType="pubmed">31567517</ArticleId></ArticleIdList></Reference><Reference><Citation>Italian ColoRectal Anastomotic Leakage (iCral) Study Group. Anastomotic leakage after elective colorectal surgery: a prospective multicentre observational study on use of the Dutch leakage score, serum procalcitonin and serum C-reactive protein for diagnosis. BJS Open. 2020;4:499&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260403</ArticleId><ArticleId IdType="pubmed">32134216</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghi F, Migliore M, Cianflocca D, et al. ; Italian ColoRectal Anastomotic Leakage (iCral) study group. Management and 1-year outcomes of anastomotic leakage after elective colorectal surgery. Int J Colorectal Dis. 2021;36:929&#x2013;939.</Citation><ArticleIdList><ArticleId IdType="pubmed">33118101</ArticleId></ArticleIdList></Reference><Reference><Citation>Augestad KM, Skyrud KD, Lindahl AK, Helgeland J. Hospital variations in failure to rescue after abdominal surgery: a nationwide, retrospective observational study. BMJ Open. 2023;13:e075018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10661059</ArticleId><ArticleId IdType="pubmed">37977874</ArticleId></ArticleIdList></Reference><Reference><Citation>Horta AB, Geraldes C, Salgado C, Vieira S, Xavier M, Papoila AL. A multivariable prediction model to select colorectal surgical patients for co-management. Acta Med Port. 2021;34:118&#x2013;127.</Citation><ArticleIdList><ArticleId IdType="pubmed">33164728</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustafsson UO, Hausel J, Thorell A, Ljungqvist O, Soop M, Nygren J; Enhanced Recovery After Surgery Study Group. Adherence to the enhanced recovery after surgery protocol and outcomes after colorectal cancer surgery. Arch Surg. 2011;146:571&#x2013;577.</Citation><ArticleIdList><ArticleId IdType="pubmed">21242424</ArticleId></ArticleIdList></Reference><Reference><Citation>Diers J, Baum P, Matthes H, Germer CT, Wiegering A. Mortality and complication management after surgery for colorectal cancer depending on the DKG minimum amounts for hospital volume. Eur J Surg Oncol. 2021;47:850&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">33020007</ArticleId></ArticleIdList></Reference><Reference><Citation>Localio AR, Berlin JA, Ten Have TR, Kimmel SE. Adjustments for center in multicenter studies: an overview. Ann Intern Med. 2001;135:112&#x2013;123.</Citation><ArticleIdList><ArticleId IdType="pubmed">11453711</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38902823</PMID><DateCompleted><Year>2024</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2025</Year><Month>05</Month><Day>05</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Genome-Wide Association Study Identifies Genes for Hair Growth and Patterning are Associated With Pilonidal Disease.</ArticleTitle><Pagination><StartPage>1149</StartPage><EndPage>1157</EndPage><MedlinePgn>1149-1157</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003308</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Pilonidal sinus disease is a highly morbid condition characterized by the formation of chronic sinus tracts throughout the sacrococcygeal region. Despite its commonality and strong association with family history, no prior investigation of genetic risk factors for pilonidal sinus disease exists.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To identify genetic risk factors for pilonidal sinus disease.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">A genome-wide association study.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">The United Kingdom Biobank, FinnGen Biobank, and Penn Medicine BioBank.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">There were 772,072 participants.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURE" NlmCategory="METHODS">Genome-wide significant variants ( p &lt; 5&#x2009;&#xd7;&#x2009;10 -8 ) were mapped to genes using physical distance and gene expression in skin. Genetic correlation between pilonidal sinus disease and morphometric, androgen-driven, and hair phenotypes was estimated with linkage disequilibrium score regression. Finally, a genome-first approach to rare predicted deleterious variants in hair shaft genes TCHH , PADI3 , and TGM3 was conducted for association with pilonidal sinus disease via the Penn Medicine BioBank.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A genome-wide association study comprising 2835 individuals with pilonidal sinus disease identified 5 genome-wide significant loci, prioritizing HDAC9, TBX15, WARS2, RP11-293M10.1 , PRKAR1B , TWIST1, GPATCH2L, NEK9 , and EIF2B2 , as putative causal genes; several of these genes have known roles in balding and hair patterning. There was a significant correlation between the genetic background of pilonidal sinus disease and the androgen-driven hair traits of male pattern baldness and young age at first facial hair. In a candidate analysis of genes associated with syndromic hair disorders, rare coding variants in TCHH , a monogenic cause of uncombable hair syndrome, were associated with increased prevalence of pilonidal sinus disease (OR 4.81 [95% CI, 2.06-11.2]).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">This study is limited to European ancestry. However, because there is a higher incidence of pilonidal sinus disease in men of European ancestry, this analysis is focused on the at-risk population.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Genetic analysis of pilonidal sinus disease identified shared genetic architecture with hair biology and androgen-driven traits. As the first study investigating the genetic basis of pilonidal sinus disease, this provides biological insight into the long-appreciated connection between the disease state, male sex, and hair. See Video abstract.</AbstractText><AbstractText Label="UN ESTUDIO DE ASOCIACIN DEL GENOMA COMPLETO IDENTIFICA GENES DEL CRECIMIENTO Y EL PATRN DEL PELO ASOCIADOS A LA ENFERMEDAD PILONIDAL" NlmCategory="UNASSIGNED">ANTECEDENTES:La enfermedad del seno pilonidal es una condici&#xf3;n muy m&#xf3;rbida caracterizada por la formaci&#xf3;n de tractos sinusales cr&#xf3;nicos en toda la regi&#xf3;n sacrococc&#xed;gea. A pesar de su frecuencia y su fuerte asociaci&#xf3;n con los antecedentes familiares, no se han investigado previamente los factores de riesgo gen&#xe9;ticos de la enfermedad sinusal pilonidal.OBJETIVO:Identificar factores gen&#xe9;ticos de riesgo para la enfermedad del seno pilonidal.DISE&#xd1;O:Estudio de asociaci&#xf3;n de genoma completo.CONJUNTOS:Biobanco del Reino Unido, Biobanco FinnGen y Biobanco PennMedicine.PACIENTES:772.072 participantes.MEDIDA DE RESULTADO PRINCIPAL:Las variantes significativas en todo el genoma (p &lt; 5x10-8) se asignaron a genes utilizando la distancia f&#xed;sica y la expresi&#xf3;n g&#xe9;nica en la piel. La correlaci&#xf3;n gen&#xe9;tica entre la enfermedad del seno pilonidal y los fenotipos morfom&#xe9;tricos, androg&#xe9;nicos y de cabello se estim&#xf3; con regresi&#xf3;n de puntuaci&#xf3;n LD. Por &#xfa;ltimo, se realiz&#xf3; una aproximaci&#xf3;n gen&#xf3;mica a variantes delet&#xe9;reas raras predichas en los genes del tallo piloso TCHH, PADI3 y TGM3 para su asociaci&#xf3;n con la enfermedad del seno pilonidal a trav&#xe9;s del Biobanco PennMedicine.RESULTADOS:El estudio de asociaci&#xf3;n de todo el genoma, que incluy&#xf3; a 2.835 individuos con enfermedad del seno pilonidal, identific&#xf3; 5 loci significativos en todo el genoma, dando prioridad a HDAC9, TBX15, WARS2, RP11-293M10.1, PRKAR1B, TWIST1, GPATCH2L, NEK9 y EIF2B2, como genes causales putativos; varios de estos genes tienen funciones conocidas en la calvicie y el patr&#xf3;n del cabello. Se observ&#xf3; una correlaci&#xf3;n significativa entre los antecedentes gen&#xe9;ticos de la enfermedad del seno pilonidal y los de los rasgos calvicie de patr&#xf3;n masculino y edad temprana del primer vello facial impulsados por andr&#xf3;genos. En un an&#xe1;lisis de genes candidatos asociados a trastornos capilares sindr&#xf3;micos, las variantes raras de codificaci&#xf3;n en TCHH, una causa monog&#xe9;nica del s&#xed;ndrome capilar incombustible, se asociaron a una mayor prevalencia de la enfermedad del seno pilonidal (OR 4,81 [IC del 5%, 2,06-11,2]).LIMITACIONES:Este estudio se limita a la ascendencia europea. Sin embargo, debido a que hay una mayor incidencia de la enfermedad sinusal pilonidal en los hombres de ascendencia europea, este an&#xe1;lisis se centra en la poblaci&#xf3;n de riesgo.CONCLUSI&#xd3;N:El an&#xe1;lisis gen&#xe9;tico de la enfermedad del seno pilonidal identific&#xf3; una arquitectura gen&#xe9;tica compartida con la biolog&#xed;a del cabello y los rasgos impulsados por andr&#xf3;genos. Siendo el primer estudio que investiga las bases gen&#xe9;ticas de la enfermedad del seno pilonidal, esto proporciona una visi&#xf3;n biol&#xf3;gica de la conexi&#xf3;n, apreciada desde hace tiempo, entre el estado de la enfermedad, el sexo masculino y el cabello. (Traducci&#xf3;n-Dr. Aurian Garcia Gonzalez ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Roberson</LastName><ForeName>Jeffrey L</ForeName><Initials>JL</Initials><Identifier Source="ORCID">0000-0002-0168-8578</Identifier><AffiliationInfo><Affiliation>Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Farzaneh</LastName><ForeName>Cyrus</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Neylan</LastName><ForeName>Christopher J</ForeName><Initials>CJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Judy</LastName><ForeName>Renae</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Walker</LastName><ForeName>Venexia</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Medical Research Council Integrative Epidemiology Unit, University of Bristol, Bristol, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Damrauer</LastName><ForeName>Scott M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Department of Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Corporal Michael J. Crescenz Memorial Veterans Affairs Medical Center, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Genetics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levin</LastName><ForeName>Michael G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maguire</LastName><ForeName>Lillias H</ForeName><Initials>LH</Initials><Identifier Source="ORCID">0000-0002-6041-2416</Identifier><AffiliationInfo><Affiliation>Division of Colon and Rectal Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Surgery, Corporal Michael J. Crescenz Memorial Veterans Affairs Medical Center, Philadelphia, Pennsylvania.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>Regeneron Genetics Center</CollectiveName></Author><Author ValidYN="Y"><CollectiveName>Penn Medicine BioBank</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010864" MajorTopicYN="Y">Pilonidal Sinus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055106" MajorTopicYN="Y">Genome-Wide Association Study</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006197" MajorTopicYN="N">Hair</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020641" MajorTopicYN="N">Polymorphism, Single Nucleotide</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>9</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>20</Day><Hour>23</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38902823</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003308</ArticleId><ArticleId IdType="pii">00003453-202409000-00009</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Johnson EK, Vogel JD, Cowan ML, Feingold DL, Steele SR; Clinical Practice Guidelines Committee of the American Society of Colon and Rectal Surgeons. The American Society of Colon and Rectal Surgeons&#x2019; Clinical Practice Guidelines for the management of pilonidal disease. Dis Colon Rectum. 2019;62:146&#x2013;157.</Citation></Reference><Reference><Citation>Chintapatla S, Safarani N, Kumar S, Haboubi N. Sacrococcygeal pilonidal sinus: historical review, pathological insight and surgical options. Tech Coloproctol. 2003;7:3&#x2013;8.</Citation></Reference><Reference><Citation>da Silva JH. Pilonidal cyst: cause and treatment. Dis Colon Rectum. 2000;43:1146&#x2013;1156.</Citation></Reference><Reference><Citation>von Laffert M, Stadie V, Ulrich J, Marsch WC, Wohlrab J. Morphology of pilonidal sinus disease: some evidence of its being a unilocalized type of hidradenitis suppurativa. Dermatology. 2011;223:349&#x2013;355.</Citation></Reference><Reference><Citation>Doll D, Dettmer M, Schumacher F, et al. Seven ideas for potential prevention of pilonidal disease and future research. Semin Colon Rectal Surg. 2022;33:ISSN 1043-1489.</Citation></Reference><Reference><Citation>Bosche F, Luedi MM, van der Zypen D, Moersdorf P, Krapohl B, Doll D. The hair in the sinus: sharp-ended rootless head hair fragments can be found in large amounts in pilonidal sinus nests. World J Surg. 2018;42:567&#x2013;573.</Citation></Reference><Reference><Citation>Doll D, Bosche F, Hauser A, et al. The presence of occipital hair in the pilonidal sinus cavity&#x2014;a triple approach to proof. Int J Colorectal Dis. 2018;33:567&#x2013;576.</Citation></Reference><Reference><Citation>Doll D, Bosche FD, Stauffer VK, et al. Strength of occipital hair as an explanation for pilonidal sinus disease caused by intruding hair. Dis Colon Rectum. 2017;60:979&#x2013;986.</Citation></Reference><Reference><Citation>Fitzpatrick EB, Chesley PM, Oguntoye MO, Maykel JA, Johnson EK, Steele SR. Pilonidal disease in a military population: how far have we really come? Am J Surg. 2014;207:907&#x2013;914.</Citation></Reference><Reference><Citation>Adjei NN, Yung N, Towers G, Caty M, Solomon D, Vash-Margita A. Establishing an association between polycystic ovarian syndrome and pilonidal disease in adolescent females. J Pediatr Adolesc Gynecol. 2023;36:39&#x2013;44.</Citation></Reference><Reference><Citation>Vasanth V, Chandrashekar BS. Follicular occlusion tetrad. Indian Dermatol Online J. 2014;5:491&#x2013;493.</Citation></Reference><Reference><Citation>Doll D, Matevossian E, Wietelmann K, Evers T, Kriner M, Petersen S. Family history of pilonidal sinus predisposes to earlier onset of disease and a 50% long-term recurrence rate. Dis Colon Rectum. 2009;52:1610&#x2013;1615.</Citation></Reference><Reference><Citation>Akinci OF, Bozer M, Uzunk&#xf6;y A, D&#xfc;zg&#xfc;n SA, Co&#x15f;kun A. Incidence and aetiological factors in pilonidal sinus among Turkish soldiers. Eur J Surg. 1999;165:339&#x2013;342.</Citation></Reference><Reference><Citation>Bolandparvaz S, Moghadam Dizaj P, Salahi R, et al. Evaluation of the risk factors of pilonidal sinus: a single center experience. Turk J Gastroenterol. 2012;23:535&#x2013;537.</Citation></Reference><Reference><Citation>Medland SE, Zhu G, Martin NG. Estimating the heritability of hair curliness in twins of European ancestry. Twin Res Hum Genet. 2009;12:514&#x2013;518.</Citation></Reference><Reference><Citation>Richards JB, Yuan X, Geller F, et al. Male-pattern baldness susceptibility locus at 20p11. Nat Genet. 2008;40:1282&#x2013;1284.</Citation></Reference><Reference><Citation>Nyholt DR, Gillespie NA, Heath AC, Martin NG. Genetic basis of male pattern baldness. J Invest Dermatol. 2003;121:1561&#x2013;1564.</Citation></Reference><Reference><Citation>Rexbye H, Petersen I, Iachina M, et al. Hair loss among elderly men: etiology and impact on perceived age. J Gerontol A Biol Sci Med Sci. 2005;60:1077&#x2013;1082.</Citation></Reference><Reference><Citation>Li R, Brockschmidt FF, Kiefer AK, et al. Six novel susceptibility loci for early-onset androgenetic alopecia and their unexpected association with common diseases. PLoS Genet. 2012;8:e1002746.</Citation></Reference><Reference><Citation>&#xdc; Basmanav FB, Cau L, Tafazzoli A, et al. Mutations in three genes encoding proteins involved in hair shaft formation cause uncombable hair syndrome. Am J Hum Genet. 2016;99:1292&#x2013;1304.</Citation></Reference><Reference><Citation>Loh PR, Tucker G, Bulik-Sullivan BK, et al. Efficient Bayesian mixed-model analysis increases association power in large cohorts. Nat Genet. 2015;47:284&#x2013;290.</Citation></Reference><Reference><Citation>Willer CJ, Li Y, Abecasis GR. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics. 2010;26:2190&#x2013;2191.</Citation></Reference><Reference><Citation>Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.</Citation></Reference><Reference><Citation>Giambartolomei C, Vukcevic D, Schadt EE, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet. 2014;10:e1004383.</Citation></Reference><Reference><Citation>Blake JA, Baldarelli R, Kadin JA, Richardson JE, Smith CL, Bult CJ; Mouse Genome Database Group. Mouse Genome Database (MGD): knowledgebase for mouse-human comparative biology. Nucleic Acids Res. 2021;49:D981&#x2013;D987.</Citation></Reference><Reference><Citation>GTEx Consortium. The GTEx Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318&#x2013;1330.</Citation></Reference><Reference><Citation>Abe S, Takeda H, Nishio SY, Usami SI. Sensorineural hearing loss and mild cardiac phenotype caused by an EYA4 mutation. Hum Genome Var. 2018;5:23.</Citation></Reference><Reference><Citation>Brockschmidt FF, Heilmann S, Ellis JA, et al. Susceptibility variants on chromosome 7p21.1 suggest HDAC9 as a new candidate gene for male-pattern baldness. Br J Dermatol. 2011;165:1293&#x2013;1302.</Citation></Reference><Reference><Citation>Chew EGY, Tan JHJ, Bahta AW, et al. Differential expression between human dermal papilla cells from balding and non-balding scalps reveals new candidate genes for androgenetic alopecia. J Invest Dermatol. 2016;136:1559&#x2013;1567.</Citation></Reference><Reference><Citation>Xu Y, Xu Y, Liao L, et al. Inducible knockout of Twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting Twist1 as a preferential cancer target. Am J Pathol. 2013;183:1281&#x2013;1292.</Citation></Reference><Reference><Citation>Farin HF, Mansouri A, Petry M, Kispert A. T-box protein Tbx18 interacts with the paired box protein Pax3 in the development of the paraxial mesoderm. J Biol Chem. 2008;283:25372&#x2013;25380.</Citation></Reference><Reference><Citation>Singh MK, Petry M, Haenig B, Lescher B, Leitges M, Kispert A. The T-box transcription factor Tbx15 is required for skeletal development. Mech Dev. 2005;122:131&#x2013;144.</Citation></Reference><Reference><Citation>Lausch E, Hermanns P, Farin HF, et al. TBX15 mutations cause craniofacial dysmorphism, hypoplasia of scapula and pelvis, and short stature in Cousin syndrome. Am J Hum Genet. 2008;83:649&#x2013;655.</Citation></Reference><Reference><Citation>Jiang CF, Xie YX, Qian YC, et al. TBX15/miR-152/KIF2C pathway regulates breast cancer doxorubicin resistance via promoting PKM2 ubiquitination. Cancer Cell Int. 2021;21:542.</Citation></Reference><Reference><Citation>Endo C, Johnson TA, Morino R, et al. Genome-wide association study in Japanese females identifies fifteen novel skin-related trait associations. Sci Rep. 2018;8:8974.</Citation></Reference><Reference><Citation>Racimo F, Gokhman D, Fumagalli M, et al. Archaic adaptive introgression in TBX15/WARS2. Mol Biol Evol. 2017;34:509&#x2013;524.</Citation></Reference><Reference><Citation>McArthur E, Rinker DC, Capra JA. Quantifying the contribution of Neanderthal introgression to the heritability of complex traits. Nat Commun. 2021;12:4481.</Citation></Reference><Reference><Citation>Torchia D. Nevus comedonicus syndrome: a systematic review of the literature. Pediatr Dermatol. 2021;38:359&#x2013;363.</Citation></Reference><Reference><Citation>&#xd6;zkan Z, Aksoy N, Emir S, et al. Investigation of the relationship between serum hormones and pilonidal sinus disease: a cross-sectional study. Colorectal Dis. 2014;16:311&#x2013;314.</Citation></Reference><Reference><Citation>Asfour L, Cranwell W, Sinclair R. Male androgenetic alopecia. In: Feingold KR, Anawalt B, Blackman MR, , eds. Endotext. South Dartmouth, MA: MDText.com Inc; 2000.</Citation></Reference><Reference><Citation>Tong Y, Zhou RY. Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia. Mediators Inflamm. 2020;2020:7958316.</Citation></Reference><Reference><Citation>Marks DH, Prasad S, De Souza B, Burns LJ, Senna MM. Topical antiandrogen therapies for androgenetic alopecia and acne vulgaris. Am J Clin Dermatol. 2020;21:245&#x2013;254.</Citation></Reference><Reference><Citation>McKusick VA. Uncombable hair syndrome 1; UHS1. OMIM. https://www.omim.org/entry/191480 . Accessed September 9, 2022.</Citation></Reference><Reference><Citation>NCBI. TCHH trichohyalin. https://www.ncbi.nlm.nih.gov/gene/7062 . Accessed September 9, 2022.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38653495</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Transitional Care in Patients With Hirschsprung Disease: Those Left Behind.</ArticleTitle><Pagination><StartPage>977</StartPage><EndPage>984</EndPage><MedlinePgn>977-984</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003208</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The long-term effects of Hirschsprung disease are clinically variable. An improved understanding of challenges patients may face as adults can help inform transitional care management.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To explore the outcomes and transitional care experiences in adult patients with Hirschsprung.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Cohort study.</AbstractText><AbstractText Label="SETTING" NlmCategory="METHODS">Single center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">All patients treated for Hirschsprung between 1977 and 2001 (aged older than 18 years at the time of survey distribution in July 2018-2019). Eligible patients were sent validated multidomain surveys and qualitative questions regarding their transitional care.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Status of transitional care, bowel function, and quality-of-life assessment. Qualitative analysis of transitional care experience.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Of 139 patients, 20 had received transition care (10 had at least 1 visit but had been discharged and 10 were receiving ongoing follow-up). These patients had inferior bowel function and quality-of-life scores at follow-up. Twenty-three patients (17%) had issues with soiling at the time of discharge, and 7 patients received transitional care. Of these 23 patients, 9 (39%) had a normal Bowel Function Score (17 or more), 5 (22%) had a poor score (less than 12), and 1 had since had a stoma formation. Eighteen patients (13%) had active moderate-severe issues related to bowel function, only 5 had been transitioned, and just 2 remained under ongoing care. Importantly, when these patients were discharged from our pediatric center, at a median age of 14 (interquartile range, 12-16) years, 10 of 17 patients had no perceptible bowel issues, suggesting a worsening of function after discharge.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The retrospective design and reliance on clinical notes to gather information on discharge status as well as patient recall of events.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There remains a small but significant proportion of Hirschsprung patients for whom bowel function either remains or becomes a major burden. These results support a need to better stratify patients requiring transitional care and ensure a clear route to care if their status changes after discharge. See Video Abstract .</AbstractText><AbstractText Label="ATENCIN DE TRANSICIN EN PACIENTES CON ENFERMEDAD DE HIRSCHSPRUNG, LOS QUE SE QUEDAN ATRS" NlmCategory="UNASSIGNED">ANTECEDENTES:Los efectos a largo plazo de la enfermedad de Hirschsprung son cl&#xed;nicamente variables. Una mejor comprensi&#xf3;n de los desaf&#xed;os que los pacientes pueden enfrentar cuando sean adultos puede ayudar a informar la gesti&#xf3;n de la atenci&#xf3;n de transici&#xf3;n.OBJETIVO:Explorar los resultados y las experiencias de atenci&#xf3;n de transici&#xf3;n en pacientes adultos con Hirschsprung.DISE&#xd1;O:Estudio de cohorte.AJUSTE:Unico centro.PACIENTES:Todos los pacientes tratados por Hirschsprung 1977-2001 (edad &gt;18 a&#xf1;os en el momento de la encuesta, Julio de 2018-2019). A los pacientes elegibles se les enviaron encuestas multidominio validadas, as&#xed; como preguntas cualitativas sobre su atenci&#xf3;n de transici&#xf3;n.PRINCIPALES MEDIDAS DE RESULTADOS:Estado de la atenci&#xf3;n de transici&#xf3;n, funci&#xf3;n intestinal y evaluaci&#xf3;n de la calidad de vida. An&#xe1;lisis cualitativo de la experiencia de cuidados transicionales.RESULTADOS:De 139 pacientes, 20 hab&#xed;an recibido atenci&#xf3;n de transici&#xf3;n (10 tuvieron al menos una visita pero hab&#xed;an sido dados de alta y 10 estaban recibiendo seguimiento continuo). Estos pacientes ten&#xed;an puntuaciones inferiores de funci&#xf3;n intestinal y calidad de vida en el seguimiento. Veintitr&#xe9;s (17%) pacientes tuvieron problemas para ensuciarse en el momento del alta y 7 recibieron atenci&#xf3;n de transici&#xf3;n. De estos, 9/23 (39%) ten&#xed;an una puntuaci&#xf3;n de funci&#xf3;n intestinal normal (&#x2265;17), 5/23 (22%) ten&#xed;an una puntuaci&#xf3;n baja (&lt;12) y un paciente hab&#xed;a tenido desde entonces una formaci&#xf3;n de estoma. Dieciocho (13%) pacientes ten&#xed;an problemas activos de moderados a graves relacionados con la funci&#xf3;n intestinal, solo cinco hab&#xed;an realizado la transici&#xf3;n y solo 2 permanec&#xed;an bajo atenci&#xf3;n continua. Es importante destacar que cuando estos pacientes fueron dados de alta de nuestro centro pedi&#xe1;trico, a una edad promedio de 14 [RIQ 12-16] a&#xf1;os, 10/17 no ten&#xed;an problemas intestinales perceptibles, lo que sugiere un empeoramiento de la funci&#xf3;n despu&#xe9;s del alta.LIMITACIONES:El dise&#xf1;o retrospectivo y la dependencia de notas cl&#xed;nicas para recopilar informaci&#xf3;n sobre el estado del alta, as&#xed; como el recuerdo de los eventos por parte del paciente.CONCLUSI&#xd3;N:Sigue existiendo una proporci&#xf3;n peque&#xf1;a pero significativa de pacientes con Hirschsprung para quienes la funci&#xf3;n intestinal permanece o se convierte en una carga importante. Estos resultados respaldan la necesidad de estratificar mejor a los pacientes que requieren atenci&#xf3;n de transici&#xf3;n y garantizar una ruta clara hacia la atenci&#xf3;n si su estado cambia despu&#xe9;s del alta. ( Traducci&#xf3;n-Dr. Yesenia Rojas-Khalil ).</AbstractText><CopyrightInformation>Copyright &#xa9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Colon and Rectal Surgeons.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>David S</ForeName><Initials>DS</Initials><AffiliationInfo><Affiliation>Department of Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davidson</LastName><ForeName>Joseph R</ForeName><Initials>JR</Initials><Identifier Source="ORCID">0000-0002-3303-6320</Identifier><AffiliationInfo><Affiliation>Department of Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ford</LastName><ForeName>Kathryn E</ForeName><Initials>KE</Initials><AffiliationInfo><Affiliation>Department of Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loukogeorgakis</LastName><ForeName>Stavros P</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>Department of Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eaton</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0003-0892-9204</Identifier><AffiliationInfo><Affiliation>Stem Cells and Regenerative Medicine Section, UCL-GOS Institute of Child Health, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blackburn</LastName><ForeName>Simon C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Department of Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curry</LastName><ForeName>Joe</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neonatal and Paediatric Surgery, Great Ormond Street Hospital for Children, London, United Kingdom.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>04</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006627" MajorTopicYN="Y">Hirschsprung Disease</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="Y">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069341" MajorTopicYN="N">Transitional Care</DescriptorName><QualifierName UI="Q000458" MajorTopicYN="N">organization &amp; administration</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005242" MajorTopicYN="N">Fecal Incontinence</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D060305" MajorTopicYN="N">Transition to Adult Care</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015331" MajorTopicYN="N">Cohort Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement><b>Financial Disclosure:</b> None reported.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>24</Day><Hour>1</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>23</Day><Hour>20</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38653495</ArticleId><ArticleId IdType="pmc">PMC11163890</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003208</ArticleId><ArticleId IdType="pii">00003453-202407000-00016</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Rintala RJ, Pakarinen MP. Outcome of anorectal malformations and Hirschsprung&#x2019;s disease beyond childhood. Semin Pediatr Surg. 2010;19:160&#x2013;167.</Citation><ArticleIdList><ArticleId IdType="pubmed">20307853</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartman EE, Oort FJ, Visser MR, et al. . Explaining change over time in quality of life of adult patients with anorectal malformations or Hirschsprung&#x2019;s disease. Dis Colon Rectum. 2006;49:96&#x2013;103.</Citation><ArticleIdList><ArticleId IdType="pubmed">16328611</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinds RJ, van der Steeg AFW, Sloots CEJ, et al. . Long-term functional outcomes and quality of life in patients with Hirschsprung disease. Br J Surg. 2019;106:499&#x2013;507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6590339</ArticleId><ArticleId IdType="pubmed">30653654</ArticleId></ArticleIdList></Reference><Reference><Citation>Jarvi K, Laitakari EM, Koivusalo A, Rintala RJ, Pakarinen MP. Bowel function and gastrointestinal quality of life among adults operated for Hirschsprung disease during childhood: a population-based study. Ann Surg. 2010;252:977&#x2013;981.</Citation><ArticleIdList><ArticleId IdType="pubmed">21107107</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuvonen MI, Kyrklund K, Lindahl HG, Koivusalo AI, Rintala RJ, Pakarinen MP. A population-based, complete follow-up of 146 consecutive patients after transanal mucosectomy for Hirschsprung disease. J Pediatr Surg. 2015;50:1653&#x2013;1658.</Citation><ArticleIdList><ArticleId IdType="pubmed">25783387</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumpitazi BP, Nurko S. Defecation disorders in children after surgery for Hirschsprung disease. J Pediatr Gastroenterol Nutr. 2011;53:75&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">21694540</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutthatarn P, Lapidus-Krol E, Smith C, et al. . Hirschsprung-associated inflammatory bowel disease: a multicenter study from the APSA Hirschsprung disease interest group. J Pediatr Surg. 2023;58:856&#x2013;861.</Citation><ArticleIdList><ArticleId IdType="pubmed">36801072</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway SJ, Craigie RJ, Cooper LH, et al. . Early adult outcome of the Duhamel procedure for left-sided Hirschsprung disease&#x2014;a prospective serial assessment study. J Pediatr Surg. 2007;42:1429&#x2013;1432.</Citation><ArticleIdList><ArticleId IdType="pubmed">17706509</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai Y, Deng Y, Lin Y, Ouyang R, Li L. Long-term outcomes and quality of life of patients with Hirschsprung disease: a systematic review and meta-analysis. BMC Gastroenterol. 2020;20:67.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7066788</ArticleId><ArticleId IdType="pubmed">32164539</ArticleId></ArticleIdList></Reference><Reference><Citation>Neuvonen MI, Kyrklund K, Rintala RJ, Pakarinen MP. Bowel function and quality of life after transanal endorectal pull-through for Hirschsprung disease: controlled outcomes up to adulthood. Ann Surg. 2017;265:622&#x2013;629.</Citation><ArticleIdList><ArticleId IdType="pubmed">28169931</ArticleId></ArticleIdList></Reference><Reference><Citation>Diseth TH, Bj&#xf8;rnland K, N&#xf8;vik TS, Emblem R. Bowel function, mental health, and psychosocial function in adolescents with Hirschsprung disease. Arch Dis Child. 1997;76:100&#x2013;106.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1717056</ArticleId><ArticleId IdType="pubmed">9068296</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson JR, Kyrklund K, Eaton S, et al. . Long-term surgical and patient-reported outcomes of Hirschsprung disease. J Pediatr Surg. 2021;56:1502&#x2013;1511.</Citation><ArticleIdList><ArticleId IdType="pubmed">33706942</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson JR, Kyrklund K, Eaton S, et al. . Sexual function, quality of life, and fertility in women who had surgery for neonatal Hirschsprung&#x2019;s disease. Br J Surg. 2021;108:e79&#x2013;e80.</Citation><ArticleIdList><ArticleId IdType="pubmed">33711127</ArticleId></ArticleIdList></Reference><Reference><Citation>Bystr&#xf6;m C, &#xd6;rtqvist L, Gunnarsd&#xf3;ttir A, Wester T, L&#xf6;f Granstr&#xf6;m A. Fertility in patients with Hirschsprung disease: population-based cohort study. BJS Open. 2023;7:zrad043.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10251299</ArticleId><ArticleId IdType="pubmed">37293939</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoel AT, Tofft L, Bj&#xf8;rnland K, et al. . Reaching adulthood with Hirschsprung&#x2019;s disease: patient experiences and recommendations for transitional care. J Pediatr Surg. 2021;56:257&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">32586610</ArticleId></ArticleIdList></Reference><Reference><Citation>Campbell F, Biggs K, Aldiss SK, et al. . Transition of care for adolescents from paediatric services to adult health services. Cochrane Database Syst Rev. 2016;4:CD009794.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10461324</ArticleId><ArticleId IdType="pubmed">27128768</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampat K, Losty PD. Transitional care and paediatric surgery. Br J Surg. 2016;103:163&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">26785645</ArticleId></ArticleIdList></Reference><Reference><Citation>Hepburn CM, Cohen E, Bhawra J, Weiser N, Hayeems RZ, Guttmann A. Health system strategies supporting transition to adult care. Arch Dis Child. 2015;100:559&#x2013;564.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4453494</ArticleId><ArticleId IdType="pubmed">25688098</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein DH, Dasgupta R; Delivery of Surgical Care Committee of the American Academy of Pediatrics Section on Surgery. Transition of care from pediatric to adult surgery. Pediatrics. 2016;138:e20161303.</Citation><ArticleIdList><ArticleId IdType="pubmed">27494943</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairo SB, Chiu PPL, Dasgupta R, et al. ; American Academy of Pediatrics Section on Surgery's Delivery of Surgical Care Committee. Transitions in care from pediatric to adult general surgery: evaluating an unmet need for patients with anorectal malformation and Hirschsprung disease. J Pediatr Surg. 2018;53:1566&#x2013;1572.</Citation><ArticleIdList><ArticleId IdType="pubmed">29079318</ArticleId></ArticleIdList></Reference><Reference><Citation>Davidson JR, Kyrklund K, Eaton S, et al. . Outcomes in Hirschsprung disease with coexisting learning disability. Eur J Pediatr. 2021;180:3499&#x2013;3507.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8589745</ArticleId><ArticleId IdType="pubmed">34115168</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenkinson C, Coulter A, Wright L. Short form 36 (SF36) health survey questionnaire: normative data for adults of working age. BMJ. 1993;306:1437&#x2013;1440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1677870</ArticleId><ArticleId IdType="pubmed">8518639</ArticleId></ArticleIdList></Reference><Reference><Citation>Taft C, Karlsson J, Sullivan M. Do SF-36 summary component scores accurately summarize subscale scores? Qual Life Res. 2001;10:395&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">11763202</ArticleId></ArticleIdList></Reference><Reference><Citation>Chun Tie Y, Birks M, Francis K. Grounded theory research: a design framework for novice researchers. SAGE Open Med. 2019;7:2050312118822927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6318722</ArticleId><ArticleId IdType="pubmed">30637106</ArticleId></ArticleIdList></Reference><Reference><Citation>Fosby MV, Stensrud KJ, Bj&#xf8;rnland K. Bowel function after transanal endorectal pull-through for Hirschsprung disease&#x2014;does outcome improve over time? J Pediatr Surg. 2020;55:2375&#x2013;2378.</Citation><ArticleIdList><ArticleId IdType="pubmed">32564909</ArticleId></ArticleIdList></Reference><Reference><Citation>Heery E, Sheehan AM, While AE, Coyne I. Experiences and outcomes of transition from pediatric to adult health care services for young people with congenital heart disease: a systematic review. Congenit Heart Dis. 2015;10:413&#x2013;427.</Citation><ArticleIdList><ArticleId IdType="pubmed">25659600</ArticleId></ArticleIdList></Reference><Reference><Citation>Foster HE, Minden K, Clemente D, et al. . EULAR/PReS standards and recommendations for the transitional care of young people with juvenile-onset rheumatic diseases. Ann Rheum Dis. 2017;76:639&#x2013;646.</Citation><ArticleIdList><ArticleId IdType="pubmed">27802961</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumagai H, Kudo T, Uchida K, et al. . Transitional care for inflammatory bowel disease: a survey of Japanese pediatric gastroenterologists. Pediatr Int. 2021;63:65&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">32621773</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee A, Bailey B, Cullen-Dean G, Aiello S, Morin J, Oechslin E. Transition of care in congenital heart disease: ensuring the proper handoff. Curr Cardiol Rep. 2017;19:55.</Citation><ArticleIdList><ArticleId IdType="pubmed">28477319</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente D, Leon L, Foster H, Minden K, Carmona L. Systematic review and critical appraisal of transitional care programmes in rheumatology. Semin Arthritis Rheum. 2016;46:372&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pubmed">27496195</ArticleId></ArticleIdList></Reference><Reference><Citation>Care Quality Commission. From the pond into the sea. Children&#x2019;s transition to adult health services.
https://www.cqc.org.uk/sites/default/files/CQC_TransitionReport.pdf. Accessed August 11, 2023.</Citation></Reference><Reference><Citation>TOFS. Congenital anomalies occurring with OA/TOF.
TOFS-11/V1. https://tofs.org.uk/product/vacterl-congenital-anomalies-occurring-with-oa-tof/. Accessed August 11, 2023.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38502565</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>13</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>7</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Low Rates of Colorectal Cancer Screening in First-Degree Relatives of Our Patients: Are We Failing Them?</ArticleTitle><Pagination><StartPage>903</StartPage><EndPage>910</EndPage><MedlinePgn>903-910</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000003189</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Guidelines recommend screening those with a family history of early-onset colorectal cancer at age 40 years or 10 years before the age of their relative's diagnosis. Currently, there is no literature reporting the screening rate in these individuals, and no protocols are in place to identify and target this population for screening awareness.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to assess adherence to current screening guidelines among first-degree relatives of patients with early-onset colorectal cancer.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective and qualitative study involving a telephone survey where patients were asked about relative's screening status and barriers to screening.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Two community-based institutions between January 2018 and December 2021.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">Individuals diagnosed with early-onset colorectal cancer who had undergone surgery at our institutions.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">Rate of screening in first-degree relatives of our patients with early-onset colorectal cancer. Other factors measured included demographics, clinicopathologic characteristics, and screening barriers.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Thirty-six patients were identified. The survey response rate was 66.6% (n = 24). A total of 88 first-degree relatives who met the screening criteria resulted in 67.1% of patients (n = 59) having a known screening status. Of the 59 patients with known screening status, only 44% (n = 26) had undergone screening. Patients of Black race, having stage III/IV disease, having Medicare/Medicaid insurance, and living within Baltimore City County were more likely to have family members with unknown or no screening. Lack of insurance coverage was the most common barrier, which was noted in 12.5% of patients (n = 3), whereas 54.1% of patients (n = 13) reported no barriers to screening.</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">Retrospective design.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Most first-degree relatives of patients diagnosed with early-onset colorectal cancer do not undergo colorectal cancer screening. This could be attributed to the lack of protocols that could guarantee these individuals are informed of their elevated risk and the different options available for screening. Furthermore, our study suggests that racial and socioeconomic disparities exist among high-risk patients who should pursue screening. See Video Abstract .</AbstractText><AbstractText Label="BAJAS TASAS DE DETECCIN DEL CNCER COLORRECTAL EN LOS FAMILIARES DE PRIMER GRADO DE NUESTROS PACIENTES LES ESTAMOS FALLANDO" NlmCategory="UNASSIGNED">ANTECEDENTES:Las directrices recomiendan realizar pruebas de detecci&#xf3;n a las personas con antecedentes familiares de c&#xe1;ncer colorrectal de aparici&#xf3;n temprana a los 40 a&#xf1;os o 10 a&#xf1;os antes de la edad del diagn&#xf3;stico de su familiar. Actualmente, no hay literatura que informe la tasa de detecci&#xf3;n en estos individuos y no existen protocolos para identificar y dirigirse a esta poblaci&#xf3;n para concientizar sobre la detecci&#xf3;n.OBJETIVO:Evaluar el cumplimiento de las pautas de detecci&#xf3;n actuales entre los FDR de pacientes con c&#xe1;ncer colorrectal de aparici&#xf3;n temprana.DISE&#xd1;O:Estudio retrospectivo y cualitativo que incluy&#xf3; una encuesta telef&#xf3;nica en la que se pregunt&#xf3; a los pacientes sobre el estado de detecci&#xf3;n de sus familiares y las barreras para la detecci&#xf3;n.AJUSTES:Dos instituciones comunitarias entre enero de 2018 y diciembre de 2021.PACIENTES:Personas diagnosticadas con c&#xe1;ncer colorrectal de inicio temprano que hab&#xed;an sido intervenidas quir&#xfa;rgicamente en nuestras instituciones.PRINCIPALES MEDIDAS DE RESULTADO:Tasa de detecci&#xf3;n en familiares de primer grado de nuestros pacientes con c&#xe1;ncer colorrectal de aparici&#xf3;n temprana. Otros factores medidos incluyeron datos demogr&#xe1;ficos, caracter&#xed;sticas cl&#xed;nico-patol&#xf3;gicas y barreras de detecci&#xf3;n.RESULTADOS:Se identificaron treinta y seis pacientes. La tasa de respuesta a la encuesta fue del 66,6% (n = 24). Resultaron un total de 88 familiares de primer grado que cumplieron con los criterios para la detecci&#xf3;n, y el 67,1% (n = 59) ten&#xed;a un estado de detecci&#xf3;n conocido. De los 59 con estado de detecci&#xf3;n conocido, se inform&#xf3; que solo el 44% (n = 26) se hab&#xed;a sometido a pruebas de detecci&#xf3;n. Los pacientes de raza afroamericana, enfermedad en etapa III/IV, Medicare/Medicaid y que viv&#xed;an dentro del condado de la ciudad de Baltimore ten&#xed;an m&#xe1;s probabilidades de tener familiares con pruebas de detecci&#xf3;n desconocidas o sin ellas. La falta de cobertura de seguro fue la barrera m&#xe1;s com&#xfa;n observada por el 12,5% (n = 3); mientras que el 54,1% (n = 13) no inform&#xf3; ninguna barrera para el cribado.LIMITACIONES:Dise&#xf1;o retrospectivo.CONCLUSIONES:La mayor&#xed;a de los familiares de primer grado de pacientes diagnosticados con c&#xe1;ncer colorrectal de aparici&#xf3;n temprana no se someten a pruebas de detecci&#xf3;n de c&#xe1;ncer colorrectal. Esto podr&#xed;a atribuirse a la falta de protocolos que garanticen que estas personas est&#xe9;n informadas sobre su elevado riesgo y las diferentes opciones disponibles para el cribado. Adem&#xe1;s, nuestro estudio sugiere que existen disparidades raciales y socioecon&#xf3;micas entre los pacientes de alto riesgo que deber&#xed;an someterse a pruebas de detecci&#xf3;n. (Traducci&#xf3;n-Dr. Francisco M. Abarca-Rendon).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2024.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Almanzar</LastName><ForeName>Anyelin</ForeName><Initials>A</Initials><Identifier Source="ORCID">0009-0003-5334-8270</Identifier><AffiliationInfo><Affiliation>Department of General Surgery, Medstar Franklin Square Medical Center, Rossville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dahmani</LastName><ForeName>Sophia L</ForeName><Initials>SL</Initials><AffiliationInfo><Affiliation>School of Medicine, Georgetown University, Washington, District of Columbia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoucair</LastName><ForeName>Sami</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Medstar Franklin Square Medical Center, Rossville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alnajjar</LastName><ForeName>Said R</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Medstar Franklin Square Medical Center, Rossville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zheng</LastName><ForeName>Kan Hong</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Medstar Franklin Square Medical Center, Rossville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Vinay K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Medstar Franklin Square Medical Center, Rossville, Maryland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lisle</LastName><ForeName>David M</ForeName><Initials>DM</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Medstar Franklin Square Medical Center, Rossville, Maryland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D059040">Video-Audio Media</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015179" MajorTopicYN="Y">Colorectal Neoplasms</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055088" MajorTopicYN="Y">Early Detection of Cancer</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019983" MajorTopicYN="N">Guideline Adherence</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005190" MajorTopicYN="N">Family</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008403" MajorTopicYN="N">Mass Screening</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036301" MajorTopicYN="N">Qualitative Research</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>13</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>3</Month><Day>19</Day><Hour>12</Hour><Minute>53</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38502565</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000003189</ArticleId><ArticleId IdType="pii">00003453-202407000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Siegel RL, Wagle NS, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2023. CA Cancer J Clin. 2023;73:233&#x2013;254.</Citation></Reference><Reference><Citation>Venugopal A, Carethers JM. Epidemiology and biology of early onset colorectal cancer. EXCLI J. 2022;21:162&#x2013;182.</Citation></Reference><Reference><Citation>Lowery JT, Ahnen DJ, Schroy PC, et al. Understanding the contribution of family history to colorectal cancer risk and its clinical implications: a state-of-the-science review. Cancer. 2016;122:2633&#x2013;2645.</Citation></Reference><Reference><Citation>Schroy PC, Barrison AF, Ling BS, Wilson S, Geller AC. Family history and colorectal cancer screening: a survey of physician knowledge and practice patterns. Am J Gastroenterol. 2002;97:1031&#x2013;1036.</Citation></Reference><Reference><Citation>Center for Disease Control and Prevention. Family health history of colorectal (colon) cancer. https://www.cdc.gov/genomics/disease/colorectal_cancer/family_history_coloretal.htm . Published March 9, 2022. Accessed April 10, 2023.</Citation></Reference><Reference><Citation>Bronner K, Mesters I, Weiss-Meilnik A, et al. Do individuals with a family history of colorectal cancer adhere to medical recommendations for the prevention of colorectal cancer? Fam Cancer. 2013;12:629&#x2013;637.</Citation></Reference><Reference><Citation>Taylor DP, Cannon-Albright LA, Sweeney C, et al. Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med. 2011;13:737&#x2013;743.</Citation></Reference><Reference><Citation>Lowery JT, Horick N, Kinney AY, et al. A randomized trial to increase colonoscopy screening in members of high-risk families in the colorectal cancer family registry and cancer genetics network. Cancer Epidemiol Biomarkers Prev. 2014;23:601&#x2013;610.</Citation></Reference><Reference><Citation>Bujanda L, Sarasqueta C, Zubiaurre L, et al.; EPICOLON Group. Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut. 2007;56:1714&#x2013;1718.</Citation></Reference><Reference><Citation>Courtney RJ, Paul CL, Carey ML, et al. A population-based cross-sectional study of colorectal cancer screening practices of first-degree relatives of colorectal cancer patients. BMC Cancer. 2013;13:13.</Citation></Reference><Reference><Citation>Tan KK, Lopez V, Wong ML, Koh GC. Uncovering the barriers to undergoing screening among first degree relatives of colorectal cancer patients: a review of qualitative literature. J Gastrointest Oncol. 2018;9:579&#x2013;588.</Citation></Reference><Reference><Citation>Sinicrope FA. Increasing incidence of early-onset colorectal cancer. N Engl J Med. 2022;386:1547&#x2013;1558.</Citation></Reference><Reference><Citation>Bailey CE, Hu C, You YN, et al. Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. JAMA Surg. 2015;150:17&#x2013;22.</Citation></Reference><Reference><Citation>Stoffel EM, Murphy CC. Epidemiology and mechanisms of the increasing incidence of colon and rectal cancers in young adults. Gastroenterology. 2020;158:341&#x2013;353.</Citation></Reference><Reference><Citation>Spaander MCW, Zauber AG, Syngal S, et al. Young-onset colorectal cancer. Nat Rev Dis Primers. 2023;9:21.</Citation></Reference><Reference><Citation>Muthukrishnan M, Arnold LD, James AS. Patients&#x2019; self-reported barriers to colon cancer screening in federally qualified health center settings. Prev Med Rep. 2019;15:100896.</Citation></Reference><Reference><Citation>Jackson CS, Oman M, Patel AM, Vega KJ. Health disparities in colorectal cancer among racial and ethnic minorities in the United States. J Gastrointest Oncol. 2016;7(suppl 1):S32&#x2013;S43.</Citation></Reference><Reference><Citation>Shah SK, Narcisse MR, Hallgren E, Felix HC, McElfish PA. Assessment of colorectal cancer screening disparities in us men and women using a demographically representative sample. Cancer Res Commun. 2022;2:561&#x2013;569.</Citation></Reference><Reference><Citation>Dougherty MK, Brenner AT, Crockett SD, et al. Evaluation of interventions intended to increase colorectal cancer screening rates in the United States: a systematic review and meta-analysis. JAMA Intern Med. 2018;178:1645&#x2013;1658.</Citation></Reference><Reference><Citation>Tai CH, Chen A, Khurana S, Mazurkiewicz R. Improving colorectal cancer screening compliance with resident education. Am J Gastroenterol. 2020;115:S1637&#x2013;S1638.</Citation></Reference><Reference><Citation>Parker S, Zipursky J, Ma H, Baumblatt GL, Siegel CA. A web-based multimedia program before colonoscopy increased knowledge and decreased anxiety, sedation requirement, and procedure time. J Clin Gastroenterol. 2018;52:519&#x2013;523.</Citation></Reference><Reference><Citation>Hart AR, Barone TL, Mayberry JF. Increasing compliance with colorectal cancer screening: the development of effective health education. Health Educ Res. 1997;12:171&#x2013;180.</Citation></Reference><Reference><Citation>Kew GS, Koh CJ. Strategies to improve persistent adherence in colorectal cancer screening. Gut Liver. 2020;14:546&#x2013;552.</Citation></Reference><Reference><Citation>Hassan C, Kaminski MF, Repici A. How to ensure patient adherence to colorectal cancer screening and surveillance in your practice. Gastroenterology. 2018;155:252&#x2013;257.</Citation></Reference><Reference><Citation>Uson PLS Jr, Riegert-Johnson D, Boardman L, et al. Germline cancer susceptibility gene testing in unselected patients with colorectal adenocarcinoma: a multicenter prospective study. Clin Gastroenterol Hepatol. 2022;20:e508&#x2013;e528.</Citation></Reference><Reference><Citation>Yurgelun MB, Kulke MH, Fuchs CS, et al. Cancer susceptibility gene mutations in individuals with colorectal cancer. J Clin Oncol. 2017;35:1086&#x2013;1095.</Citation></Reference><Reference><Citation>You YN, Moskowitz JB, Chang GJ, et al. Germline cancer risk profiles of patients with young-onset colorectal cancer: findings from a prospective universal germline testing and telegenetics program. Dis Colon Rectum. 2023;66:531&#x2013;542.</Citation></Reference><Reference><Citation>Pearlman R, Frankel WL, Swanson B, et al.; Ohio Colorectal Cancer Prevention Initiative Study Group. Prevalence and spectrum of germline cancer susceptibility gene mutations among patients with early-onset colorectal cancer. JAMA Oncol. 2017;3:464&#x2013;471.</Citation></Reference><Reference><Citation>Pearlman R, Frankel WL, Swanson BJ, et al. Prospective statewide study of universal screening for hereditary colorectal cancer: the Ohio colorectal cancer prevention initiative. JCO Precis Oncol. 2021;5:779&#x2013;791.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37929276</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1578-1860</ISSN><JournalIssue CitedMedium="Internet"><Volume>223</Volume><Issue>5</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Revista clinica espanola</Title><ISOAbbreviation>Rev Clin Esp</ISOAbbreviation></Journal><ArticleTitle>S&#xed;ndrome de Wiskott-Aldrich en Espa&#xf1;a: incidencia, mortalidad y sesgo de g&#xe9;nero durante 21 a&#xf1;os.</ArticleTitle><Pagination><StartPage>262</StartPage><EndPage>269</EndPage><MedlinePgn>262-269</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.rce.2023.02.008</ELocationID><Abstract><AbstractText Label="ANTECEDENTES" NlmCategory="UNASSIGNED">El s&#xed;ndrome de Wiskott-Aldrich (SWA) es un raro trastorno ligado al cromosoma X que se considera que afecta predominantemente a varones.</AbstractText><AbstractText Label="OBJETIVO" NlmCategory="UNASSIGNED">El objetivo de este estudio consist&#xed;a en investigar la incidencia y la mortalidad intrahospitalaria del SWA en Espa&#xf1;a, as&#xed; como el sesgo de g&#xe9;nero.</AbstractText><AbstractText Label="M&#xc9;TODOS" NlmCategory="UNASSIGNED">Se llev&#xf3; a cabo un estudio epidemiol&#xf3;gico retrospectivo poblacional en 97 pacientes con SWA diagnosticados en hospitales espa&#xf1;oles entre 1997 y 2017, utilizando para ello datos del Sistema Nacional de Vigilancia de Datos Hospitalarios.</AbstractText><AbstractText Label="RESULTADOS" NlmCategory="UNASSIGNED">Nuestros resultados revelaron que la incidencia anual media del SAW en Espa&#xf1;a fue de 1,1 caso por cada 10 millones de habitantes (IC del 95 %, 0,45-2,33). El riesgo relativo fue mayor en los varones que en las mujeres (2,42). El diagn&#xf3;stico de SWA se establece a una edad m&#xe1;s avanzada en las mujeres (mediana de 47 a&#xf1;os) que en los varones (mediana de 5,5 a&#xf1;os). &#xda;nicamente los varones ingresaron en el hospital en al menos 10 ocasiones diferentes y todas las muertes se detectaron en varones. La tasa de mortalidad intrahospitalaria fue del 9,28 % en el SAW y la mayor&#xed;a de las muertes se asociaron a hemorragia cerebral o infecci&#xf3;n.</AbstractText><AbstractText Label="CONCLUSIONES" NlmCategory="UNASSIGNED">El SWA, una enfermedad rara, se diagnostica a una edad m&#xe1;s avanzada en las mujeres y la mortalidad se observ&#xf3; exclusivamente en varones, asociada en la mayor&#xed;a de los casos a hemorragia cerebral e infecci&#xf3;n.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Espejo</LastName><ForeName>Antonio Guerrero</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n de Enfermedades Infecciosas, Facultad de Medicina y Odontolog&#xed;a, Universidad Cat&#xf3;lica de Valencia "San Vicente M&#xe1;rtir", Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dols</LastName><ForeName>Sof&#xed;a Tom&#xe1;s</ForeName><Initials>ST</Initials><AffiliationInfo><Affiliation>Grupo de Investigaci&#xf3;n de Enfermedades Infecciosas, Facultad de Medicina y Odontolog&#xed;a, Universidad Cat&#xf3;lica de Valencia "San Vicente M&#xe1;rtir", Valencia, Espa&#xf1;a.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gestal</LastName><ForeName>M&#xf3;nica C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Servicio de Microbiolog&#xed;a e Inmunolog&#xed;a. LSU Health, 71103, Shreveport, LA, Estados Unidos.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P01 AI127335</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P20 GM134974</GrantID><Acronym>GM</Acronym><Agency>NIGMS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Spain</Country><MedlineTA>Rev Clin Esp</MedlineTA><NlmUniqueID>8608576</NlmUniqueID><ISSNLinking>0014-2565</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Espa&#xf1;a</Keyword><Keyword MajorTopicYN="N">S&#xed;ndrome de Wiskott-Aldrich</Keyword><Keyword MajorTopicYN="N">epidemiolog&#xed;a</Keyword><Keyword MajorTopicYN="N">incidencia</Keyword><Keyword MajorTopicYN="N">mortalidad</Keyword><Keyword MajorTopicYN="N">mujeres</Keyword></KeywordList><CoiStatement>8.Conflictos de intereses Los autores declaran carecer de conflictos de intereses.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>6</Day><Hour>4</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37929276</ArticleId><ArticleId IdType="mid">NIHMS1895939</ArticleId><ArticleId IdType="pmc">PMC10621733</ArticleId><ArticleId IdType="doi">10.1016/j.rce.2023.02.008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Notarangelo LD, Miao CH, Ochs HD. Wiskott-Aldrich syndrome. Curr Opin Hematol. 2008;15(1):30&#x2013;6. 10.1097/MOH.0b013e3282f30448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0b013e3282f30448</ArticleId><ArticleId IdType="pubmed">18043243</ArticleId></ArticleIdList></Reference><Reference><Citation>Massaad MJ, Ramesh N, Geha RS. Wiskott-Aldrich syndrome: A comprehensive review. Ann N Y Acad Sci. 2013;1285(1):26&#x2013;43. 10.1111/nyas.12049</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nyas.12049</ArticleId><ArticleId IdType="pubmed">23527602</ArticleId></ArticleIdList></Reference><Reference><Citation>Blundell MP, Worth A, Bouma G, Thrasher AJ. The Wiskott-Aldrich Syndrome: The Actin Cytoskeleton and Immune Cell Function. Dis Markers. 2010;29(3&#x2013;4). 10.1155/2010/781523</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2010/781523</ArticleId><ArticleId IdType="pmc">PMC3835520</ArticleId><ArticleId IdType="pubmed">21178275</ArticleId></ArticleIdList></Reference><Reference><Citation>Garkaby J, Upton J. Wiskott-Aldrich syndrome caused by a novel mutation in the WAS gene and presenting with a mild phenotype. LymphoSign J. 2021;8(3). 10.14785/lymphosign-2021-0022</Citation><ArticleIdList><ArticleId IdType="doi">10.14785/lymphosign-2021-0022</ArticleId></ArticleIdList></Reference><Reference><Citation>Candotti F. Clinical Manifestations and Pathophysiological Mechanisms of the Wiskott-Aldrich Syndrome. J Clin Immunol. 2018;38:13&#x2013;27. 10.1007/s10875-017-0453-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-017-0453-z</ArticleId><ArticleId IdType="pubmed">29086100</ArticleId></ArticleIdList></Reference><Reference><Citation>Sudhakar M, Rikhi R, Loganathan SK, Suri D, Singh S. Autoimmunity in wiskott&#x2013;aldrich syndrome: Updated perspectives. Appl Clin Genet. 2021;14(20):363&#x2013;88. 10.2147/TACG.S213920</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TACG.S213920</ArticleId><ArticleId IdType="pmc">PMC8384432</ArticleId><ArticleId IdType="pubmed">34447261</ArticleId></ArticleIdList></Reference><Reference><Citation>Du S, Scuderi R, Malicki DM, Willert J, Bastian J, Weidner N. Hodgkin&#x2019;s and non-Hodgkin&#x2019;s lymphomas occurring in two brothers with Wiskott-Aldrich syndrome and review of the literature. Pediatr Dev Pathol. 2011;14(1). 10.2350/10-01-0787-CR.1</Citation><ArticleIdList><ArticleId IdType="doi">10.2350/10-01-0787-CR.1</ArticleId><ArticleId IdType="pubmed">20429642</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchbinder D, Nugent DJ, Fillipovich AH. Wiskott-Aldrich syndrome: Diagnosis, current management, and emerging treatments. Appl Clin Genet. 2014;7:55&#x2013;66. 10.2147/TACG.S58444</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/TACG.S58444</ArticleId><ArticleId IdType="pmc">PMC4012343</ArticleId><ArticleId IdType="pubmed">24817816</ArticleId></ArticleIdList></Reference><Reference><Citation>Mallhi KK, Petrovic A, Ochs HD. Hematopoietic stem cell therapy for wiskott&#x2013; aldrich syndrome: Improved outcome and quality of life. J Blood Med. 2021;12:435&#x2013;47. 10.2147/JBM.S232650</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JBM.S232650</ArticleId><ArticleId IdType="pmc">PMC8206065</ArticleId><ArticleId IdType="pubmed">34149291</ArticleId></ArticleIdList></Reference><Reference><Citation>Candotti F. Gene therapy for Wiskott-Aldrich syndrome: here to stay. Lancet Haematol. 2019;6(5):e230&#x2013;1. 10.1016/S2352-3026(19)30066-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(19)30066-3</ArticleId><ArticleId IdType="pubmed">30981782</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah AJ, Sokolic R, Logan B, Yin Z, Iyengar S, Scalchunes C, et al. Quality of Life of Patients with Wiskott Aldrich Syndrome and X-Linked Thrombocytopenia: a Study of the Primary Immune Deficiency Consortium (PIDTC), Immune Deficiency Foundation, and the Wiskott-Aldrich Foundation. J Clin Immunol. 2019;39(8):786&#x2013;94. 10.1007/s10875-019-00689-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-019-00689-2</ArticleId><ArticleId IdType="pmc">PMC7385986</ArticleId><ArticleId IdType="pubmed">31620947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrua F, Cicalese MP, Galimberti S, Giannelli S, Dionisio F, Barzaghi F, et al. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study. Lancet Haematol. 2019;6(5):e239&#x2013;53. 10.1016/S2352-3026(19)30021-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(19)30021-3</ArticleId><ArticleId IdType="pmc">PMC6494976</ArticleId><ArticleId IdType="pubmed">30981783</ArticleId></ArticleIdList></Reference><Reference><Citation>Magnani A, Semeraro M, Adam F, Booth C, Dupr&#xe9; L, Morris EC, et al. Long-term safety and efficacy of lentiviral hematopoietic stem/progenitor cell gene therapy for Wiskott&#x2013;Aldrich syndrome. Nat Med. 2022. Jan 1 [cited 2022 May 2];28(1):71&#x2013;80. 10.1038/S41591-021-01641-X</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/S41591-021-01641-X</ArticleId><ArticleId IdType="pmc">PMC8799465</ArticleId><ArticleId IdType="pubmed">35075289</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal N, Sridhar DC, Malay S, Patil N, Shekar A, Ahuja S, et al. Wiskott Aldrich syndrome: healthcare utilizations and disparities in transplant care. Sci Rep. 2021;11(1):1&#x2013;7. 10.1038/s41598-021-84328-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84328-0</ArticleId><ArticleId IdType="pmc">PMC7907136</ArticleId><ArticleId IdType="pubmed">33633315</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacein-Bey Abina S, Gaspar HB, Blondeau J, Caccavelli L, Charrier S, Buckland K, et al. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome. JAMA - J Am Med Assoc. 2015;313(15):1550&#x2013;63. 10.1001/jama.2015.3253</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2015.3253</ArticleId><ArticleId IdType="pmc">PMC4942841</ArticleId><ArticleId IdType="pubmed">25898053</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero A, Torres P, Duran MT, Ruiz-D&#xed;ez B, Rosales M, Rodriguez-Tudela JL. Airborne outbreak of nosocomial Scedosporium prolificans infection. Lancet. 2001;357(9264):1267&#x2013;8. 10.1016/S0140-6736(00)04423-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(00)04423-8</ArticleId><ArticleId IdType="pubmed">11418156</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero A, Cobo J, Fort&#xfa;n J, Navas E, Quereda C, Asensio A, et al. Nosocomial transmission of Mycobacterium bovis resistant to 11 drugs in people with advanced HIV-1 infection. Lancet. 1997. Dec 13;350(9093):1738&#x2013;42. 10.1016/S0140-6736(97)07567-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(97)07567-3</ArticleId><ArticleId IdType="pubmed">9413465</ArticleId></ArticleIdList></Reference><Reference><Citation>Rivers E, Worth A, Thrasher AJ, Burns SO. How I manage patients with Wiskott Aldrich syndrome. Br J Haematol. 2019;185(4):647&#x2013;55. 10.1111/bjh.15831</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.15831</ArticleId><ArticleId IdType="pmc">PMC7612067</ArticleId><ArticleId IdType="pubmed">30864154</ArticleId></ArticleIdList></Reference><Reference><Citation>Villa A, Notarangelo L, Macchi P, Mantuano E, Cavagni G, Brugnoni D, et al. X&#x2013;linked thrombocytopenia and Wiskott&#x2013;Aldrich syndrome are allelic diseases with mutations in the WASP gene. Nat Genet. 1995;9(4):414&#x2013;7. 10.1038/ng0495-414</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng0495-414</ArticleId><ArticleId IdType="pubmed">7795648</ArticleId></ArticleIdList></Reference><Reference><Citation>Parolini O, Ressmann G, Oskar A. Haas O, Pawlowsky J, Gadner H, Knapp W, et al. X-Linked Wiskott&#x2013;Aldrich Syndrome in a Girl. N Engl J Med. 1998;338(5):291&#x2013;5. 10.1056/NEJM199801293380504</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199801293380504</ArticleId><ArticleId IdType="pubmed">9445409</ArticleId></ArticleIdList></Reference><Reference><Citation>Fearon ER, Kohn DB, Winkelstein JA, Vogelstein B, Blaese RM. Carrier detection in the Wiskott Aldrich syndrome. Blood. 1988;72(5):1735&#x2013;9. 10.1182/blood.v72.5.1735.1735</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.v72.5.1735.1735</ArticleId><ArticleId IdType="pubmed">3263154</ArticleId></ArticleIdList></Reference><Reference><Citation>Greer WL, Kwong PC, Peacocke M, Ip P, Rubin LA, Siminovitch KA. X-Chromosome inactivation in the Wiskott-Aldrich syndrome: A marker for detection of the carrier state and identfication of cell lineages expressing the gene defect. Genomics. 1989;4(1):60&#x2013;7. 10.1016/0888-7543(89)90315-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0888-7543(89)90315-7</ArticleId><ArticleId IdType="pubmed">2563352</ArticleId></ArticleIdList></Reference><Reference><Citation>Wengler BG, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Cell. 1995;85(9):2471&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7537115</ArticleId></ArticleIdList></Reference><Reference><Citation>Boonyawat B, Dhanraj S, Al Abbas F, Zlateska B, Grunenbaum E, Roifman CM, et al. Combined de-novo mutation and non-random X-chromosome inactivation causing Wiskott-Aldrich syndrome in a female with thrombocytopenia. J Clin Immunol. 2013;33(7):1150&#x2013;5. 10.1007/s10875-013-9927-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10875-013-9927-9</ArticleId><ArticleId IdType="pubmed">23943155</ArticleId></ArticleIdList></Reference><Reference><Citation>Conley M, Wang W, Parolini O, Shapiro DN, Campana D, Siminovitch KA. Atypical Wiskott-Aldrich Syndrome in a Girl. Blood. 1992;80(5):1264&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">1515642</ArticleId></ArticleIdList></Reference><Reference><Citation>Russell SJ, Nisen PD. Random X chromosome inactivation in a female with a variant of Wiskott&#x2010;Aldrich syndrome. Br J Haematol 1995;90(1):210&#x2013;2. 10.1111/j.13652141.1995.tb03403.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.13652141.1995.tb03403.x</ArticleId><ArticleId IdType="pubmed">7786787</ArticleId></ArticleIdList></Reference><Reference><Citation>Kondoh T, Hayashi K, Matsumoto T, Yoshimoto M, Morio T, Yata J, et al. Two sisters with clinical diagnosis of Wiskott-Aldrich syndrome: Is the condition in the family autosomal recessive? Am J Med Genet - Neuropsychiatr Genet. 1995;60(5):364&#x2013;9. 10.1002/ajmg.1320600504</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.1320600504</ArticleId><ArticleId IdType="pubmed">8546147</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryser O, Morell A, Hitzig WH. Primary immunodeficiencies in Switzerland: First report of the national registry in adults and children. J Clin Immunol. 1988;8(6):479&#x2013;85. 10.1007/BF00916954</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00916954</ArticleId><ArticleId IdType="pubmed">3065352</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry GS, Spector BD, Schuman LM, Mandel JS, Anderson VE, McHugh RB, et al. The Wiskott-Aldrich syndrome in the United States and Canada (1892&#x2013;1979). J Pediatr. 1980;97(1):72&#x2013;8. 10.1016/s0022-3476(80)80133-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0022-3476(80)80133-8</ArticleId><ArticleId IdType="pubmed">7381651</ArticleId></ArticleIdList></Reference><Reference><Citation>Blancas-Galicia L, Escamilla-Quiroz C, Yamazaki-Nakashimada MA. S&#xed;ndrome de Wiskott-Aldrich; revisi&#xf3;n actualizada. Rev Alerg Mex. 2011;58(4):213&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">24007832</ArticleId></ArticleIdList></Reference><Reference><Citation>Stucki U, Spycher MA, Eich G, Rossi A, Sacher P, Steinmann B, et al. Identification of WASP mutations in 14 Spanish families with Wiskott-Aldrich syndrome. Am J Med Genet. 2001;100(2):116&#x2013;21. 10.1002/ajmg.1228</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajmg.1228</ArticleId><ArticleId IdType="pubmed">11298372</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu N, Garc&#xed;a-Rodr&#xed;guez M, Volpini V, Frecha C, Molina IJ, Fontan G, et al. A novel Wiskott-Aldrich syndrome protein (WASP) complex mutation identified in a WAS patient results in an aberrant product at the C-terminus from two transcripts with unusual polyA signals. J Hum Genet [Internet]. 2006;51(2):92&#x2013;7. Available from: 10.1007/s10038-005-03287</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10038-005-03287</ArticleId><ArticleId IdType="pubmed">16372137</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochs HD, Filipovich AH, Veys P, Cowan MJ, Kapoor N. Wiskott-Aldrich Syndrome: Diagnosis, Clinical and Laboratory Manifestations, and Treatment. Biol Blood Marrow Transplant. 2009;15(1, Supplement):84&#x2013;90. 10.1016/j.bbmt.2008.10.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbmt.2008.10.007</ArticleId><ArticleId IdType="pubmed">19147084</ArticleId></ArticleIdList></Reference><Reference><Citation>Matamoros Flor&#xed; N, Mila Llambi J, Espanol Boren T, Raga Borja S, Fontan Casariego G. Primary Immunodeficiency Syndrome in Spain: First Report of the National Registry in Children and Adults. J Clin Immunol. 1997;17(4):333&#x2013;9. 10.1023/a:1027382916924</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1027382916924</ArticleId><ArticleId IdType="pubmed">9258772</ArticleId></ArticleIdList></Reference><Reference><Citation>Stray-Pedersen A, Abrahamsen TG, Fr&#xf8;land SS. Primary Immunodeficiency Diseases in Norway. J Clin Immunol. 2000;20(6):477&#x2013;85. 10.1023/a:1026416017763.</Citation><ArticleIdList><ArticleId IdType="doi">10.1023/a:1026416017763</ArticleId><ArticleId IdType="pubmed">11202238</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheminant M, Mahlaoui N, Desconclois C, Canioni D, Ysebaert L, Dupr&#xe9; L, et al. Lymphoproliferative disease in patients with Wiskott-Aldrich syndrome: Analysis of the French Registry of Primary Immunodeficiencies. J Allergy Clin Immunol. 2019;143(6):2311&#x2013;2315.e7. 10.1016/j.jaci.2019.01.046</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2019.01.046</ArticleId><ArticleId IdType="pubmed">30796981</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin Y, Mazza C, Christie JR, Giliani S, Fiorini M, Mella P, et al. Mutations of the Wiskott-Aldrich Syndrome Protein (WASP): Hotspots, effect on transcription, and translation and phenotype/genotype correlation. Blood. 2004;104(13):4010&#x2013;9. 10.1182/blood-2003-05-1592</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-05-1592</ArticleId><ArticleId IdType="pubmed">15284122</ArticleId></ArticleIdList></Reference><Reference><Citation>Imai K, Morio T, Zhu Y, Jin Y, Itoh S, Kajiwara M, et al. Clinical course of patients with WASP gene mutations. Blood 2004. Jan 15;103(2):456&#x2013;64. 10.1182/blood-2003-051480.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2003-051480</ArticleId><ArticleId IdType="pubmed">12969986</ArticleId></ArticleIdList></Reference><Reference><Citation>De Saint Basile G, Lagelouse RD, Lambert N, Schwarz K, Le Mareck B, Odent S, et al. Isolated X-linked thrombocytopenia in two unrelated families is associated with point mutations in the Wiskott-Aldrich syndrome protein gene. J Pediatr. 1996;129(1):56&#x2013;62. 10.1016/S0022-3476(96)70190-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(96)70190-7</ArticleId><ArticleId IdType="pubmed">8757563</ArticleId></ArticleIdList></Reference><Reference><Citation>Ariga T, Yamada M, Wada T, Saitoh S, Sakiyama Y. Detection of lymphocytes and granulocytes expressing the mutant WASP message in carriers of Wiskott-Aldrich syndrome. Br J Haematol. 1999;104(4):893&#x2013;900. 10.1046/j.1365-2141.1999.01248.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2141.1999.01248.x</ArticleId><ArticleId IdType="pubmed">10192456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutskiy MI, Sasahara Y, Kenney DM, Rosen FS, Remold-O&#x2019;Donnell E. Wiskott-Aldrich syndrome in a female. Blood. 2002. Oct 15;100(8):2763&#x2013;8. 10.1182/blood-2002-02-0388</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-02-0388</ArticleId><ArticleId IdType="pubmed">12351383</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreu N, Pujol-Moix N, Martinez-Lostao L, Oset M, Mu&#xf1;iz-Diaz E, Estivill X, et al. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation. Blood Cells, Mol Dis. 2003;31(3):332&#x2013;7. 10.1016/S1079-9796(03)00168-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1079-9796(03)00168-2</ArticleId><ArticleId IdType="pubmed">14636648</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou X, Sun J, Liu C, Hao J. Case Report: Wiskott-Aldrich Syndrome Caused by Extremely Skewed X-Chromosome Inactivation in a Chinese Girl. Front Pediatr. 2021;9(July):1&#x2013;5. 10.3389/fped.2021.691524</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fped.2021.691524</ArticleId><ArticleId IdType="pmc">PMC8295588</ArticleId><ArticleId IdType="pubmed">34307257</ArticleId></ArticleIdList></Reference><Reference><Citation>Takimoto T, Takada H, Ishimura M, Kirino M, Hata K, Ohara O, et al. Wiskott-aldrich syndrome in a girl caused by heterozygous WASP mutation and extremely skewed X-chromosome inactivation: A novel association with maternal uniparental isodisomy 6. Neonatology. 2015;107(3):185&#x2013;90. 10.1159/000370059</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000370059</ArticleId><ArticleId IdType="pubmed">25633059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA. A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr. 1994;125(6 PART 1):876&#x2013;85. 10.1016/S00223476(05)82002-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S00223476(05)82002-5</ArticleId><ArticleId IdType="pubmed">7996359</ArticleId></ArticleIdList></Reference><Reference><Citation>Suri D, Rikhi R, Jindal AK, Rawat A, Sudhakar M, Vignesh P, et al. Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India. Front Immunol. 2021;12(April):1&#x2013;14. 10.3389/fimmu.2021.627651</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.627651</ArticleId><ArticleId IdType="pmc">PMC8086834</ArticleId><ArticleId IdType="pubmed">33936041</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37815326</PMID><DateCompleted><Year>2024</Year><Month>01</Month><Day>12</Day></DateCompleted><DateRevised><Year>2025</Year><Month>02</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1530-0358</ISSN><JournalIssue CitedMedium="Internet"><Volume>67</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Feb</Month><Day>01</Day></PubDate></JournalIssue><Title>Diseases of the colon and rectum</Title><ISOAbbreviation>Dis Colon Rectum</ISOAbbreviation></Journal><ArticleTitle>Validation of a Clinical Calculator Predicting Freedom From Colon Cancer Recurrence After Surgery on the Basis of Molecular and Clinical Variables.</ArticleTitle><Pagination><StartPage>240</StartPage><EndPage>245</EndPage><MedlinePgn>240-245</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1097/DCR.0000000000002896</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Memorial Sloan Kettering clinical calculator for estimating the likelihood of freedom from colon cancer recurrence on the basis of clinical and molecular variables was developed at a time when testing for microsatellite instability was performed selectively, based on patient age, family history, and histologic features. Microsatellite stability was assumed if no testing was done.</AbstractText><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This study aimed to validate the calculator in a cohort of patients who had all been tested for microsatellite instability.</AbstractText><AbstractText Label="DESIGN" NlmCategory="METHODS">Retrospective cohort analysis.</AbstractText><AbstractText Label="SETTINGS" NlmCategory="METHODS">Comprehensive cancer center.</AbstractText><AbstractText Label="PATIENTS" NlmCategory="METHODS">This study included consecutive patients who underwent curative resection for stage I, II, or III colon cancer between 2017 and 2019.</AbstractText><AbstractText Label="INTERVENTION" NlmCategory="METHODS">Universal testing of mircrosatellite phenotype in all cases.</AbstractText><AbstractText Label="MAIN OUTCOME MEASURES" NlmCategory="METHODS">The calculator's predictive accuracy was assessed using the concordance index and a calibration plot of predicted versus actual freedom from recurrence at 3 years after surgery. For a secondary sensitivity analysis, the presence of a tumor deposit(s) (disease category N1c) was considered equivalent to one positive lymph node (category N1a).</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">With a median follow-up of 32 months among survivors, the concordance index for the 745 patients in the cohort was 0.748 (95% CI, 0.693-0.801), and a plot of predicted versus observed recurrences approached the 45&#xb0; diagonal, indicating good discrimination and calibration. In the secondary sensitivity analysis for tumor deposits, the concordance index was 0.755 (95% CI, 0.700-0.806).</AbstractText><AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">This study was limited by its retrospective, single-institution design.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results, based on inclusion of actual rather than imputed microsatellite stability status and presence of tumor deposits, confirm the predictive accuracy and reliability of the calculator. See Video Abstract .</AbstractText><AbstractText Label="VALIDACIN DE UNA CALCULADORA CLNICA QUE PREDICE LA AUSENCIA DE RECURRENCIA POSTQUIRURGICA DEL CNCER DE COLON SOBRE LA BASE DE VARIABLES MOLECULARES Y CLNICAS" NlmCategory="UNASSIGNED">ANTECEDENTES:La calculadora cl&#xed;nica del Memorial Sloan Kettering para la estimaci&#xf3;n de la probabilidad de ausencia de recurrencia del c&#xe1;ncer de colon sobre la base de variables cl&#xed;nicas y moleculares, se desarroll&#xf3; en un momento en que las pruebas para la inestabilidad de microsat&#xe9;lites se realizaban de forma selectiva, basadas en la edad del paciente, los antecedentes familiares y las caracter&#xed;sticas histol&#xf3;gicas. Se asum&#xed;a la estabilidad micro satelital si no se realizaba ninguna prueba.OBJETIVO:El objetivo de este estudio fue validar la calculadora en una cohorte de pacientes a los que se les hab&#xed;a realizado la prueba de inestabilidad de microsat&#xe9;lites.DISE&#xd1;O:An&#xe1;lisis de cohorte retrospectivo.AJUSTE:Centro integral de c&#xe1;ncer.PACIENTES:Pacientes consecutivos con c&#xe1;ncer de colon que fueron sometidos a resecci&#xf3;n curativa por c&#xe1;ncer de colon en estadios I, II o III entre los a&#xf1;os 2017 y 2019.PRINCIPALES MEDIDAS DE RESULTADO:La precisi&#xf3;n predictiva de la calculadora fue evaluada mediante el &#xed;ndice de concordancia y un gr&#xe1;fico de calibraci&#xf3;n de la ausencia de recurrencia predecida versus la real a los 3 a&#xf1;os tras la cirug&#xed;a. A los efectos de un an&#xe1;lisis secundario de sensibilidad, la presencia de dep&#xf3;sito(s) tumoral(es) (categor&#xed;a de enfermedad N1c) se consider&#xf3; equivalente a un ganglio linf&#xe1;tico positivo (categor&#xed;a N1a).RESULTADOS:Con una mediana de seguimiento de 32 meses entre los supervivientes, el &#xed;ndice de concordancia para los 745 pacientes de la cohorte fue de 0,748 (intervalo de confianza del 95 %, 0,693 a 0,801), y una gr&#xe1;fica de recurrencias previstas versus observadas se acerc&#xf3; a la diagonal de 45&#xb0;, indicando una buena discriminaci&#xf3;n y calibraci&#xf3;n. En el an&#xe1;lisis secundario de sensibilidad para dep&#xf3;sitos tumorales, el &#xed;ndice de concordancia fue de 0,755 (intervalo de confianza del 95 %, 0,700 a 0,806).LIMITACIONES:Dise&#xf1;o retrospectivo, instituci&#xf3;n &#xfa;nica.CONCLUSIONES:Estos resultados, basados en la inclusi&#xf3;n real del estado de estabilidad de microsat&#xe9;lites en lugar de imputado y la presencia de dep&#xf3;sitos tumorales, confirman la precisi&#xf3;n predictiva y la confiabilidad de la calculadora. (Traducci&#xf3;n-Dr Osvaldo Gauto ).</AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2023.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Asama</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Thompson</LastName><ForeName>Hannah M</ForeName><Initials>HM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hsu</LastName><ForeName>Meier</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Widmar</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wei</LastName><ForeName>Iris H</ForeName><Initials>IH</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pappou</LastName><ForeName>Emmanouil</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>J Joshua</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nash</LastName><ForeName>Garrett M</ForeName><Initials>GM</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Paty</LastName><ForeName>Philip B</ForeName><Initials>PB</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Aguilar</LastName><ForeName>Julio</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shia</LastName><ForeName>Jinru</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xf6;nen</LastName><ForeName>Mithat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Weiser</LastName><ForeName>Martin R</ForeName><Initials>MR</Initials><Identifier Source="ORCID">0000-0002-9577-7984</Identifier><AffiliationInfo><Affiliation>Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30CA008748</GrantID><Acronym>CA</Acronym><Agency>NCI NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D059040">Video-Audio Media</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Dis Colon Rectum</MedlineTA><NlmUniqueID>0372764</NlmUniqueID><ISSNLinking>0012-3706</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D049451" MajorTopicYN="Y">Nomograms</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079822" MajorTopicYN="N">Extranodal Extension</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053842" MajorTopicYN="N">Microsatellite Instability</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015203" MajorTopicYN="N">Reproducibility of Results</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003110" MajorTopicYN="Y">Colonic Neoplasms</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName></MeshHeading></MeshHeadingList><OtherAbstract Type="Publisher" Language="spa"><AbstractText Label="ANTECEDENTES:">La calculadora cl&#xed;nica Memorial Sloan Kettering para estimar la probabilidad de ausencia de recurrencia del c&#xe1;ncer de colon sobre la base de variables cl&#xed;nicas y moleculares se desarroll&#xf3; en un momento en que las pruebas para la inestabilidad de microsat&#xe9;lites se realizaban de forma selectiva, seg&#xfa;n la edad del paciente, los antecedentes familiares y la histolog&#xed;a. caracter&#xed;sticas. Se asumi&#xf3; la estabilidad del microsat&#xe9;lite si no se realizaba ninguna prueba.</AbstractText><AbstractText Label="OBJETIVO:">El objetivo de este estudio fue validar la calculadora en una cohorte de pacientes a los que se les hab&#xed;a realizado la prueba de inestabilidad de microsat&#xe9;lites.</AbstractText><AbstractText Label="DISE&#xd1;O:">An&#xe1;lisis de cohorte retrospectivo.</AbstractText><AbstractText Label="AJUSTE:">Centro integral de c&#xe1;ncer.</AbstractText><AbstractText Label="PACIENTES:">pacientes consecutivos con c&#xe1;ncer de colon que se sometieron a una resecci&#xf3;n curativa por c&#xe1;ncer de colon en estadio I, II o III entre 2017 y 2019.</AbstractText><AbstractText Label="PRINCIPALES MEDIDAS DE RESULTADO:">La precisi&#xf3;n predictiva de la calculadora se evalu&#xf3; mediante el &#xed;ndice de concordancia y un gr&#xe1;fico de calibraci&#xf3;n de la ausencia de recurrencia predicha versus real a los 3 a&#xf1;os despu&#xe9;s de la cirug&#xed;a. A los efectos de un an&#xe1;lisis de sensibilidad secundario, la presencia de dep&#xf3;sito(s) tumoral(es) (categor&#xed;a de enfermedad N1c) se consider&#xf3; equivalente a un ganglio linf&#xe1;tico positivo (categor&#xed;a N1a).</AbstractText><AbstractText Label="RESULTADOS:">Con una mediana de seguimiento de 32 meses entre los supervivientes, el &#xed;ndice de concordancia para los 745 pacientes de la cohorte fue de 0,748 (intervalo de confianza del 95 %, 0,693 a 0,801), y una gr&#xe1;fica de recurrencias previstas versus observadas se acerc&#xf3; a la diagonal de 45&#xb0;, indicando una buena discriminaci&#xf3;n y calibraci&#xf3;n. En el an&#xe1;lisis de sensibilidad secundario para dep&#xf3;sitos tumorales, el &#xed;ndice de concordancia fue de 0,755 (intervalo de confianza del 95 %, 0,700 a 0,806).</AbstractText><AbstractText Label="LIMITACIONES:">Dise&#xf1;o retrospectivo, instituci&#xf3;n &#xfa;nica.</AbstractText><AbstractText Label="CONCLUSIONES:">Estos resultados, basados &#x200b;&#x200b;en la inclusi&#xf3;n del estado de estabilidad de microsat&#xe9;lites real en lugar de imputado y la presencia de dep&#xf3;sitos tumorales, confirman la precisi&#xf3;n predictiva y la confiabilidad de la calculadora. Consulte Video Resumen en http://links.lww.com/DCR/Bxxx. <i>(Pre-proofed version)</i></AbstractText><CopyrightInformation>Copyright &#xa9; The ASCRS 2023.</CopyrightInformation></OtherAbstract></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>1</Month><Day>12</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>12</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>10</Day><Hour>8</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2025</Year><Month>2</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37815326</ArticleId><ArticleId IdType="mid">NIHMS1935727</ArticleId><ArticleId IdType="pmc">PMC10843082</ArticleId><ArticleId IdType="doi">10.1097/DCR.0000000000002896</ArticleId><ArticleId IdType="pii">00003453-202402000-00008</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Weiser MR, Landmann RG, Kattan MW, et al. Individualized prediction of colon cancer recurrence using a nomogram. J Clin Oncol. 2008;26:380&#x2013;385.</Citation><ArticleIdList><ArticleId IdType="pubmed">18202413</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser MR, Hsu M, Bauer PS, et al. Clinical calculator based on molecular and clinicopathologic characteristics predicts recurrence following resection of stage I-III colon cancer. J Clin Oncol. 2021;39:911&#x2013;919.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189618</ArticleId><ArticleId IdType="pubmed">33439688</ArticleId></ArticleIdList></Reference><Reference><Citation>Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16:e173&#x2013;e180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4465353</ArticleId><ArticleId IdType="pubmed">25846097</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins IM, Kelleher F, Stuart C, Collins M, Kennedy J. Clinical decision aids in colon cancer: a comparison of two predictive nomograms. Clin Colorectal Cancer. 2012;11:138&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">22018885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kazem MA, Khan AU, Selvasekar CR. Validation of nomogram for disease free survival for colon cancer in UK population: A prospective cohort study. Int J Surg. 2016;27:58&#x2013;65.</Citation><ArticleIdList><ArticleId IdType="pubmed">26796369</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi T, Shimada Y, Hsu M, et al. Contemporary validation of a nomogram predicting colon cancer recurrence, revealing all-stage improved outcomes. JNCI Cancer Spectr. 2019;3:pkz015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6512350</ArticleId><ArticleId IdType="pubmed">31119207</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M, Qu H, Bu Z, et al. Validation of the memorial sloan-kettering cancer center nomogram to predict overall survival after curative colectomy in a chinese colon cancer population. Ann Surg Oncol. 2015;22:3881&#x2013;3887.</Citation><ArticleIdList><ArticleId IdType="pubmed">25963477</ArticleId></ArticleIdList></Reference><Reference><Citation>College of American Pathologists. Protocol for the examination of specimens from patients with primary carcinoma of the colon and rectum, version 4.0.1.0. https://documents.cap.org/protocols/cp-gilower-colonrectum-17protocol-4010.pdf.
Accessed March 1, 2023.</Citation></Reference><Reference><Citation>Shia J, Stadler Z, Weiser MR, et al. Immunohistochemical staining for DNA mismatch repair proteins in intestinal tract carcinoma: how reliable are biopsy samples? Am J Surg Pathol. 2011;35:447&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pubmed">21297438</ArticleId></ArticleIdList></Reference><Reference><Citation>Stadler ZK, Battaglin F, Middha S, et al. Reliable detection of mismatch repair deficiency in colorectal cancers using mutational load in next-generation sequencing panels. J Clin Oncol. 2016;34:2141&#x2013;2147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4962706</ArticleId><ArticleId IdType="pubmed">27022117</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagtegaal ID, Knijn N, Hugen N, et al. Tumor deposits in colorectal cancer: improving the value of modern staging-a systematic review and meta-analysis. J Clin Oncol. 2017;35:1119&#x2013;1127.</Citation><ArticleIdList><ArticleId IdType="pubmed">28029327</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin M, Frankel WL. Lymph node metastasis in colorectal cancer. Surg Oncol Clin N Am. 2018;27:401&#x2013;412.</Citation><ArticleIdList><ArticleId IdType="pubmed">29496097</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno H, Mochizuki H, Akagi Y, et al. Optimal colorectal cancer staging criteria in TNM classification. J Clin Oncol. 2012;30:1519&#x2013;1526.</Citation><ArticleIdList><ArticleId IdType="pubmed">22430272</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin MB, Edge SB, Greene FL. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017.</Citation></Reference><Reference><Citation>Cheng DT, Mitchell TN, Zehir A, et al. Memorial Sloan Kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn. 2015;17:251&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5808190</ArticleId><ArticleId IdType="pubmed">25801821</ArticleId></ArticleIdList></Reference><Reference><Citation>Shia J, Black D, Hummer AJ, Boyd J, Soslow RA. Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer. Hum Pathol. 2008;39:116&#x2013;125.</Citation><ArticleIdList><ArticleId IdType="pubmed">17949789</ArticleId></ArticleIdList></Reference><Reference><Citation>National Comprehensive Cancer Network. NCCN guidelines: colon cancer. https://www.nccn.org/login?ReturnURL=https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf; Accessed November 3 2022.</Citation></Reference><Reference><Citation>Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15:361&#x2013;387.</Citation><ArticleIdList><ArticleId IdType="pubmed">8668867</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyrk TC, Watson P, Kaul K, Lynch HT. Tumor-infiltrating lymphocytes are a marker for microsatellite instability in colorectal carcinoma. Cancer. 2001;91:2417&#x2013;2422.</Citation><ArticleIdList><ArticleId IdType="pubmed">11413533</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaf&#xe0; R, Maestri I, Matteuzzi M, et al. Sporadic colorectal adenocarcinomas with high-frequency microsatellite instability. Cancer. 2000;89:2025&#x2013;2037.</Citation><ArticleIdList><ArticleId IdType="pubmed">11066042</ArticleId></ArticleIdList></Reference><Reference><Citation>Edge SBBD, Compton CC, Fritz AG, Greene FL, Trotti A. AJCC cancer staging manual 7ed. New York: Springer, 2010.</Citation></Reference><Reference><Citation>Cohen R, Shi Q, Meyers J, et al. Combining tumor deposits with the number of lymph node metastases to improve the prognostic accuracy in stage III colon cancer: a post hoc analysis of the CALGB/SWOG 80702 phase III study (Alliance). Ann Oncol. 2021;32:1267&#x2013;1275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8719434</ArticleId><ArticleId IdType="pubmed">34293461</ArticleId></ArticleIdList></Reference><Reference><Citation>Delattre JF, Cohen R, Henriques J, et al. Prognostic value of tumor deposits for disease-free survival in patients with stage III colon cancer: a post hoc analysis of the IDEA France phase III trial (PRODIGE-GERCOR). J Clin Oncol. 2020;38:1702&#x2013;1710.</Citation><ArticleIdList><ArticleId IdType="pubmed">32167864</ArticleId></ArticleIdList></Reference><Reference><Citation>Konishi T, Shimada Y, Lee LH, et al. Poorly differentiated clusters predict colon cancer recurrence: an in-depth comparative analysis of invasive-front prognostic markers. Am J Surg Pathol. 2018;42:705&#x2013;714.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5943141</ArticleId><ArticleId IdType="pubmed">29624511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoshino N, Hasegawa S, Hida K, et al. Nomogram for predicting recurrence in stage II colorectal cancer. Acta Oncol. 2016;55:1414&#x2013;1417.</Citation><ArticleIdList><ArticleId IdType="pubmed">27581839</ArticleId></ArticleIdList></Reference><Reference><Citation>Osterman E, Ekstrom J, Sjoblom T, et al. Accurate population-based model for individual prediction of colon cancer recurrence. Acta Oncol. 2021;60:1241&#x2013;1249.</Citation><ArticleIdList><ArticleId IdType="pubmed">34279175</ArticleId></ArticleIdList></Reference><Reference><Citation>Renfro LA, Grothey A, Xue Y, et al. ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer. J Natl Cancer Inst. 2014;106:dju333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4334801</ArticleId><ArticleId IdType="pubmed">25359867</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar SN, Hu CY, Snyder RA, et al. Predicting risk of recurrence after colorectal cancer surgery in the United States: an analysis of a special commission on cancer national study. Ann Surg Oncol. 2020;27:2740&#x2013;2749.</Citation><ArticleIdList><ArticleId IdType="pubmed">32080809</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno H, Hase K, Hashiguchi Y, et al. Site-specific tumor grading system in colorectal cancer: multicenter pathologic review of the value of quantifying poorly differentiated clusters. Am J Surg Pathol. 2014;38:197&#x2013;204.</Citation><ArticleIdList><ArticleId IdType="pubmed">24418853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ueno H, Shinto E, Kajiwara Y, et al. Prognostic impact of histological categorisation of epithelial-mesenchymal transition in colorectal cancer. Br J Cancer. 2014;111:2082&#x2013;2090.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4260033</ArticleId><ArticleId IdType="pubmed">25247323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zlobec I, Lugli A. Invasive front of colorectal cancer: dynamic interface of pro-/anti-tumor factors. World J Gastroenterol. 2009;15:5898&#x2013;5906.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2795176</ArticleId><ArticleId IdType="pubmed">20014453</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiser MR, Chou JF, Keshinro A, et al. Development and assessment of a clinical calculator for estimating the likelihood of recurrence and survival among patients with locally advanced rectal cancer treated with chemotherapy, radiotherapy, and surgery. JAMA Netw Open. 2021;4:e2133457.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576585</ArticleId><ArticleId IdType="pubmed">34748003</ArticleId></ArticleIdList></Reference><Reference><Citation>Moons KG, Royston P, Vergouwe Y, Grobbee DE, Altman DG. Prognosis and prognostic research: what, why, and how? BMJ. 2009;338:b375.</Citation><ArticleIdList><ArticleId IdType="pubmed">19237405</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>